<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<xbrli:xbrl xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:kcac="http://www.kensingtoncapital.com/20200930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="kcac-20200930.xsd"/>
	<xbrli:context id="C_0001811414_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="xbrli_shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="iso4217_USD">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="iso4217_USD_xbrli_shares">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="xbrli_pure">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="kcac_Vote">
		<xbrli:measure>kcac:Vote</xbrli:measure>
	</xbrli:unit>
	<xbrli:context id="C_0001811414_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">kcac:ClassACommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">kcac:ClassACommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200416">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200416">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200416">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200416">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200416">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200628_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200628_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200628_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200628_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacExchangedWarrantsMember_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:ExchangedWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:OriginalHolderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:NewHoldersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:OriginalHolderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:NewHoldersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:OriginalHolderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:NewHoldersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:OriginalHolderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">kcac:NewHoldersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">kcac:SubscriptionAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">kcac:SubscriptionAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">kcac:SeniorEmployeeLockUpAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">kcac:SeniorEmployeeLockUpAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-02</xbrli:startDate>
			<xbrli:endDate>2020-09-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_20200929_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-29</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200929_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-29</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDebtInstrumentAxis_kcacWorkingCapitalLoansMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_us-gaapUSTreasurySecuritiesMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">kcac:ClassACommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacUnderwritersSharesMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">kcac:UnderwritersSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">kcac:ClassACommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-04-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-25</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200417_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-04-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200417_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-04-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200417_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDebtInstrumentAxis_kcacPromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDebtInstrumentAxis_kcacPromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapDebtInstrumentAxis_kcacWorkingCapitalLoansMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtTitleOfIndividualAxis_srtChiefFinancialOfficerMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200417_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200417">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-17</xbrli:startDate>
			<xbrli:endDate>2020-04-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-25</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200625_20200625">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-25</xbrli:startDate>
			<xbrli:endDate>2020-06-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625_20200625">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-25</xbrli:startDate>
			<xbrli:endDate>2020-06-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_srtRangeAxis_srtMaximumMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPublicWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPublicWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-01</xbrli:startDate>
			<xbrli:endDate>2020-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="C_0001811414_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_20200930">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<dei:DocumentType contextRef="C_0001811414_20200417_20200930">S-1</dei:DocumentType>
	<dei:AmendmentFlag contextRef="C_0001811414_20200417_20200930">false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef="C_0001811414_20200417_20200930">QuantumScape Corp</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef="C_0001811414_20200417_20200930">0001811414</dei:EntityCentralIndexKey>
	<dei:EntityFilerCategory contextRef="C_0001811414_20200417_20200930">Non-accelerated Filer</dei:EntityFilerCategory>
	<dei:EntitySmallBusiness contextRef="C_0001811414_20200417_20200930">true</dei:EntitySmallBusiness>
	<dei:EntityEmergingGrowthCompany contextRef="C_0001811414_20200417_20200930">true</dei:EntityEmergingGrowthCompany>
	<dei:EntityExTransitionPeriod contextRef="C_0001811414_20200417_20200930">false</dei:EntityExTransitionPeriod>
	<dei:EntityIncorporationStateCountryCode contextRef="C_0001811414_20200417_20200930">DE</dei:EntityIncorporationStateCountryCode>
	<dei:EntityTaxIdentificationNumber contextRef="C_0001811414_20200417_20200930">85-0796578</dei:EntityTaxIdentificationNumber>
	<dei:EntityAddressAddressLine1 contextRef="C_0001811414_20200417_20200930">1400 Old Country Road</dei:EntityAddressAddressLine1>
	<dei:EntityAddressAddressLine2 contextRef="C_0001811414_20200417_20200930">Suite 301</dei:EntityAddressAddressLine2>
	<dei:EntityAddressCityOrTown contextRef="C_0001811414_20200417_20200930">Westbury</dei:EntityAddressCityOrTown>
	<dei:EntityAddressStateOrProvince contextRef="C_0001811414_20200417_20200930">NY</dei:EntityAddressStateOrProvince>
	<dei:EntityAddressPostalZipCode contextRef="C_0001811414_20200417_20200930">11590</dei:EntityAddressPostalZipCode>
	<dei:CityAreaCode contextRef="C_0001811414_20200417_20200930">703</dei:CityAreaCode>
	<dei:LocalPhoneNumber contextRef="C_0001811414_20200417_20200930">674-6514</dei:LocalPhoneNumber>
	<us-gaap:Cash contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">1002785</us-gaap:Cash>
	<us-gaap:PrepaidExpenseCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">285083</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:AssetsCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">1287868</us-gaap:AssetsCurrent>
	<kcac:InvestmentsHeldInTrustAccount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">230075599</kcac:InvestmentsHeldInTrustAccount>
	<us-gaap:Assets contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">231363467</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">15238</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">1155999</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">90548</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">75000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">1336785</us-gaap:LiabilitiesCurrent>
	<kcac:DeferredUnderwritingCommissionsNoncurrent contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">8050000</kcac:DeferredUnderwritingCommissionsNoncurrent>
	<us-gaap:Liabilities contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">9386785</us-gaap:Liabilities>
	<us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="C_0001811414_20200930" unitRef="iso4217_USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/>
	<us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">216976680</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
	<us-gaap:PreferredStockValue xsi:nil="true" contextRef="C_0001811414_20200930" unitRef="iso4217_USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/>
	<us-gaap:CommonStockValue contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="0" unitRef="iso4217_USD">130</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="0" unitRef="iso4217_USD">575</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">6524748</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">-1525451</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">5000002</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">231363467</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
	<us-gaap:TemporaryEquitySharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">21697668</us-gaap:TemporaryEquitySharesOutstanding>
	<us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">100000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">1302332</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">1302332</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="xbrli_shares">10000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="C_0001811414_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized contextRef="C_0001811414_20200930" decimals="INF" unitRef="xbrli_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued contextRef="C_0001811414_20200930" decimals="INF" unitRef="xbrli_shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding contextRef="C_0001811414_20200930" decimals="INF" unitRef="xbrli_shares">0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">1428188</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">1430502</us-gaap:GeneralAndAdministrativeExpense>
	<kcac:AdministrativeExpensesRelatedParty contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">60000</kcac:AdministrativeExpensesRelatedParty>
	<kcac:AdministrativeExpensesRelatedParty contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">80000</kcac:AdministrativeExpensesRelatedParty>
	<us-gaap:FranchisorCosts contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">50000</us-gaap:FranchisorCosts>
	<us-gaap:FranchisorCosts contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">90548</us-gaap:FranchisorCosts>
	<us-gaap:OperatingIncomeLoss contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1538223</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">1601085</us-gaap:OperatingIncomeLoss>
	<kcac:NetGainFromInvestmentsHeldInTrustAccount contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">75599</kcac:NetGainFromInvestmentsHeldInTrustAccount>
	<kcac:NetGainFromInvestmentsHeldInTrustAccount contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">75599</kcac:NetGainFromInvestmentsHeldInTrustAccount>
	<us-gaap:NetIncomeLoss contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1462589</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">-1525451</us-gaap:NetIncomeLoss>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="F_000086_10-Q" contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="xbrli_shares">7053922</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="F_000087_10-Q" contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="xbrli_shares">6248452</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="C_0001811414_20200701_20200930" decimals="2" unitRef="iso4217_USD_xbrli_shares">-0.20</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="C_0001811414_20200417_20200930" decimals="2" unitRef="iso4217_USD_xbrli_shares">-0.24</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200701_20200930" decimals="INF" unitRef="xbrli_shares">21697668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200417_20200930" decimals="INF" unitRef="xbrli_shares">21697668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200416" decimals="INF" unitRef="xbrli_shares">0</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200416" decimals="0" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200416" decimals="INF" unitRef="xbrli_shares">0</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200416" decimals="0" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200416" decimals="0" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200416" decimals="0" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_20200416" decimals="0" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200630" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">575</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">24425</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630" decimals="INF" unitRef="xbrli_shares">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">2300</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
	<us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">229997700</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
	<us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">230000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">13097867</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="C_0001811414_20200417_20200630" decimals="0" unitRef="iso4217_USD">13097867</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">6575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">6575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
	<kcac:NumberOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200417_20200630" decimals="INF" unitRef="xbrli_shares">21843927</kcac:NumberOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">2184</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">218437086</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_20200417_20200630" decimals="0" unitRef="iso4217_USD">218439270</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<us-gaap:NetIncomeLoss contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200417_20200630" decimals="0" unitRef="iso4217_USD">-62862</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="C_0001811414_20200417_20200630" decimals="0" unitRef="iso4217_USD">-62862</us-gaap:NetIncomeLoss>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200630" decimals="INF" unitRef="xbrli_shares">1156073</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200630" decimals="0" unitRef="iso4217_USD">116</us-gaap:StockholdersEquity>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200630" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200630" decimals="0" unitRef="iso4217_USD">575</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630" decimals="0" unitRef="iso4217_USD">5062172</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630" decimals="0" unitRef="iso4217_USD">-62862</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_20200630" decimals="0" unitRef="iso4217_USD">5000001</us-gaap:StockholdersEquity>
	<kcac:NumberOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930" decimals="INF" unitRef="xbrli_shares">-146259</kcac:NumberOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930" decimals="0" unitRef="iso4217_USD">-14</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1462576</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1462590</kcac:ValueOfSharesSubjectToPossibleRedemption>
	<us-gaap:NetIncomeLoss contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1462589</us-gaap:NetIncomeLoss>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="0" unitRef="iso4217_USD">130</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="0" unitRef="iso4217_USD">575</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200930" decimals="0" unitRef="iso4217_USD">6524748</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200930" decimals="0" unitRef="iso4217_USD">-1525451</us-gaap:StockholdersEquity>
	<us-gaap:ProfitLoss contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">1525451</us-gaap:ProfitLoss>
	<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">285083</us-gaap:IncreaseDecreaseInPrepaidExpense>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">15238</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">1070999</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInPropertyAndOtherTaxesPayable contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">90548</us-gaap:IncreaseDecreaseInPropertyAndOtherTaxesPayable>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">-709348</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">230000000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">-230000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromNotesPayable contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">75000</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
	<us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">6575000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
	<us-gaap:PaymentsOfStockIssuanceCosts contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">4962867</us-gaap:PaymentsOfStockIssuanceCosts>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">231712133</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">1002785</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">1002785</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
	<kcac:NonCashOfferingCostsIncludedInAccruedExpenses contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">85000</kcac:NonCashOfferingCostsIncludedInAccruedExpenses>
	<kcac:NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">8050000</kcac:NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering>
	<us-gaap:StockIssued1 contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">216976680</us-gaap:StockIssued1>
	<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 1&amp;#8212;Description of Organization and Business Operations &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Kensington Capital Acquisition Corp. (the &amp;#8220;Company&amp;#8221;) was incorporated in Delaware on April 17, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &amp;#8220;Business Combination&amp;#8221;). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company has focused its search for a target business in the automotive and automotive-related sector. The Company is an &amp;#8220;emerging growth company,&amp;#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &amp;#8220;JOBS Act&amp;#8221;), and as such is subject to all of the risks associated with emerging growth companies.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On &lt;font style="color:#000000;"&gt;September 2, 2020&lt;/font&gt;, the Company entered into &lt;font style="color:#000000;"&gt;a business combination agreement and plan of reorganization (as amended on September 21, 2020 and as may be further amended from time to time, the &amp;#8220;QS Business Combination Agreement&amp;#8221;)&lt;/font&gt;, by and among the Company, &lt;font style="color:#000000;"&gt;Kensington Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of the Company (&amp;#8220;Merger Sub&amp;#8221;), and QuantumScape Corporation., a Delaware corporation (&amp;#8220;QuantumScape&amp;#8221;). &lt;/font&gt;&lt;font style="Background-color:#FFFFFF;"&gt;Merger Sub will merge with and into QuantumScape, with QuantumScape surviving the merger and becoming a wholly-owned direct subsidiary of the Company (collectively with the other transactions described in the QS Business Combination Agreement, the &amp;#8220;QS Business Combination,&amp;#8221; or the &amp;#8220;Proposed Transactions&amp;#8221;). &lt;/font&gt;&lt;font style="color:#000000;"&gt;QuantumScape is a leader in the development of next generation solid-state lithium-metal batteries for use in electric vehicles. See the Proposed Transactions described below.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of September 30, 2020, the Company had not commenced any operations. All activity for the period from April 17, 2020 (inception) through September 30, 2020 relates to the Company&amp;#8217;s formation and the initial public offering (the &amp;#8220;Initial Public Offering&amp;#8221;) described below, the identification and evaluation of prospective acquisition targets for an initial Business Combination, including the Proposed Transactions (as defined below), and ongoing administrative and compliance matters. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s sponsor is Kensington Capital Sponsor LLC, a Delaware limited liability company (the &amp;#8220;Sponsor&amp;#8221;, or the &amp;#8220;Original Holder&amp;#8221;). &lt;font style="Background-color:#FFFFFF;"&gt;The registration statement for the Company&amp;#8217;s Initial Public Offering was declared effective on June 25, 2020. On June&amp;#160;30, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the &amp;#8220;Units&amp;#8221; and, with respect to the Class A common stock included in the Units sold, the &amp;#8220;Public Shares&amp;#8221;), including 3,000,000 additional Units to cover over-allotments (the &amp;#8220;Over-Allotment Units&amp;#8221;), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.1 million, inclusive of approximately $8.1 million in deferred underwriting commissions (Note 5).&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="Background-color:#FFFFFF;"&gt;Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&amp;#8220;Private Placement&amp;#8221;) of &lt;/font&gt;6,575,000 &lt;font style="Background-color:#FFFFFF;"&gt;warrants (each, a &amp;#8220;Private Placement Warrant&amp;#8221; and collectively, the &amp;#8220;Private Placement Warrants&amp;#8221;) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $6.6 million (Note 4).&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon the closing of the Initial Public Offering &lt;font style="Background-color:#FFFFFF;"&gt;and the Private Placement&lt;/font&gt;, $230.0 million ($10.00 per Unit) &lt;font style="Background-color:#FFFFFF;"&gt; of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement &lt;/font&gt;was held in a trust account (&amp;#8220;Trust Account&amp;#8221;) located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and invested only in U.S. &amp;#8220;government securities,&amp;#8221; within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the &amp;#8220;Investment Company Act&amp;#8221;).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide holders of the Company&amp;#8217;s outstanding shares of Class A common stock, par value $0.0001 per share, sold in the Initial Public Offering (the &amp;#8220;Public Stockholders&amp;#8221;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $10.00 per Public Share), calculated as of two business days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company&amp;#8217;s taxes, net of taxes payable. The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the &amp;#8220;Certificate of Incorporation&amp;#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company holds a stockholder vote or there is a tender offer for shares in connection with an initial Business Combination, the Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $ per Public Share), calculated as of two business days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company&amp;#8217;s taxes, net of taxes payable. The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). As a result, such Public Shares are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board&amp;#8217;s (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 480 &amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Certificate of Incorporation provided that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &amp;#8220;group&amp;#8221; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the &amp;#8220;Exchange Act&amp;#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Sponsor and the Company&amp;#8217;s officers and directors (the &amp;#8220;initial stockholders&amp;#8221;) agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A) to modify the substance or timing of the Company&amp;#8217;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to stockholders&amp;#8217; rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding Public Shares.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or June 30, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the &amp;#8220;Combination Period&amp;#8221;), the Company will (i) &lt;font style="color:#231F20;"&gt;cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&amp;#8217;s taxes, net of taxes payable (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&amp;#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&amp;#8217;s remaining stockholders and the Company&amp;#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&amp;#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&lt;/font&gt; &lt;font style="color:#231F20;"&gt;There will be no redemption rights or liquidating distributions with respect to the Company&amp;#8217;s warrants, which will expire worthless if the Company fails to complete its initial Business Combination within the Combination Period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company&amp;#8217;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a &amp;#8220;Target&amp;#8221;), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company&amp;#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commencing August 17, 2020, holders of the Units were permitted to elect to separately trade the shares of Class A common stock and Warrants (as defined below) included in the Units. No fractional shares will be issued upon separation of the Units and only whole Warrants will trade.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Proposed Business Combination and Related Transactions&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 2, 2020, the Company, Kensington Merger Sub Inc., wholly owned subsidiary of the Company (&amp;#8220;Merger Sub&amp;#8221;), and QuantumScape Corporation. (&amp;#8220;QuantumScape&amp;#8221;), entered into the QS Business Combination Agreement, pursuant to which, among other things, the Company and QuantumScape will enter into the QS Business Combination&lt;font style="Background-color:#FFFFFF;"&gt;. &lt;/font&gt;QuantumScape is a leader in the development of next generation solid-state lithium-metal batteries for use in electric vehicles.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="Background-color:#FFFFFF;"&gt;At the closing of the QS Business Combination (the &amp;#8220;Closing&amp;#8221;), each outstanding share of QuantumScape Class&amp;#160;A common stock, together with each share of QuantumScape preferred stock that is outstanding immediately prior to the Closing and convertible into a share of QuantumScape Class&amp;#160;A common stock pursuant to the provisions of QuantumScape&amp;#8217;s certificate of incorporation, and each outstanding share of QuantumScape Class&amp;#160;B common stock, together with each share of QuantumScape preferred stock that is outstanding immediately prior to the Closing and convertible into a share of QuantumScape Class&amp;#160;B common stock pursuant to the provisions of QuantumScape&amp;#8217;s certificate of incorporation, will be cancelled and automatically converted into the right to receive a number of shares of the Company&amp;#8217;s Class&amp;#160;A common stock or shares of the Company&amp;#8217;s Class&amp;#160;B common stock, as applicable, determined in each case by reference to an &amp;#8220;Exchange Ratio,&amp;#8221; calculated in accordance with the QS Business Combination Agreement. As of the date of the initial signing of the QS Business Combination Agreement, the Exchange Ratio was 4.0032186234, and the Company will file with the SEC a Current Report on Form&amp;#160;8-K&amp;#160;announcing the final Exchange Ratio no later than four business days prior to a special meeting of its stockholders.&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As a result of the QS Business Combination, the Company currently expects to issue with respect to QuantumScape Capital Stock (or expects to reserve for issuance with respect to Exchanged Options, Exchanged RSUs and Exchanged Warrants (each as defined below)) 368,799,998 shares of the Company&amp;#8217;s Common Stock in the aggregate. The final aggregate amount of shares of the Company&amp;#8217;s Common Stock to be issued (or reserved for issuance) in connection with the business combination will be calculated in accordance with the QS Business Combination Agreement.&lt;/p&gt;
&lt;p style="text-align:justify;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As &lt;font style="color:#000000;"&gt;promptly as practicable after the Proxy statement, prospectus, and information statement becomes effective, QuantumScape will seek an irrevocable written consent of QuantumScape&amp;#8217;s stockholders as required to approve and adopt the QS Business Combination Agreement and the Proposed Transactions. Such approval will be sought from and requires the affirmative vote of the holders of at least (a)&amp;#160;a majority of the outstanding shares of QuantumScape capital stock, (b)&amp;#160;a majority of the outstanding shares of QuantumScape Class&amp;#160;A common stock and the outstanding shares of QuantumScape Class&amp;#160;B common stock, each voting separately as a class, (c)&amp;#160;a majority of the outstanding shares of QuantumScape Class&amp;#160;A common stock and shares of QuantumScape preferred stock that are convertible into shares of QuantumScape Class&amp;#160;A common stock, voting as a single class, and (d)&amp;#160;a majority of the outstanding shares of QuantumScape Class&amp;#160;B common stock and the outstanding shares of QuantumScape preferred stock that are convertible into shares of QuantumScape Class&amp;#160;B common stock, voting together as a single class. No additional approval or vote from any holders of any class or series of stock of QuantumScape will be necessary to adopt and approve the QS Business Combination Agreement, the QS Business Combination and the Proposed Transactions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The transaction is structured as a reverse triangular merger, which includes the following: (a) Pursuant to the QS Business Combination Agreement, on the Closing Date, Merger Sub will be merged with and into QuantumScape (the &amp;#8220;Merger&amp;#8221;), with QuantumScape surviving the Merger as a wholly-owned direct subsidiary of the Company (the &amp;#8220;Surviving Corporation&amp;#8221;); (b) Contemporaneously with the execution of the QS Business Combination Agreement, certain investors have entered into certain subscription agreements, pursuant to which such investors will purchase shares of the Company&amp;#8217;s Common Stock at a purchase price of $10.00 per share in a private placement to be consummated immediately prior to the consummation of the Proposed Transactions; (c) In addition, concurrently with the execution of the QS Business Combination Agreement, (i) the Company, QuantumScape and Volkswagen Group of America Investments LLC (&amp;#8220;Volkswagen&amp;#8221;) entered into a stockholder support agreement (the &amp;#8220;Volkswagen Support Agreement&amp;#8221;), pursuant to which, among other things, Volkswagen agreed, among other things, to vote its shares of QuantumScape Preferred Stock in favor of the QS Business Combination Agreement and the Proposed Transactions, and (ii) the Company, QuantumScape and certain stockholders of QuantumScape with (together with Volkswagen) a sufficient number of votes to approve the Merger and other transactions that require the approval of QuantumScape&amp;#8217;s stockholders entered into a stockholder support agreement (the &amp;#8220;Other Stockholder Support Agreement&amp;#8221;; the Volkswagen Stockholder Support Agreement and the Other Stockholder Support Agreement, the &amp;#8220;Stockholder Support Agreements&amp;#8221;), pursuant to which, among other things, the Key QuantumScape Stockholders agreed, among other things, to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the QS Business Combination Agreement and the Proposed Transactions; and (iii) certain stockholders of QuantumScape and certain stockholders of the Company entered into a registration rights and lock-up agreement (the &amp;#8220;Registration Rights and Lock-Up Agreement&amp;#8221;); (d) In addition, concurrently with the execution of the QS Business Combination Agreement, certain senior level employees of QuantumScape entered into a lock-up agreement (the &amp;#8220;Senior Employee Lock-Up Agreement&amp;#8221;) with the Company, pursuant to which, such employees agreed to restrictions on the transferability of the Company&amp;#8217;s securities for a period of up to four years following the consummation of the Proposed Transactions, subject to certain exceptions set forth therein; and (e) In addition, concurrently with the execution of the QS Business Combination Agreement, (i) the Company and QuantumScape entered into a letter agreement with Volkswagen Group of America Investments, LLC (&amp;#8220;VGA&amp;#8221;), a stockholder of QuantumScape, pursuant to which, consistent with the rights of VGA with respect to the election of QuantumScape&amp;#8217;s directors under the existing voting agreement between QuantumScape and certain of its stockholders, VGA will be entitled, following the Proposed Transactions, to nominate up to two designees to the Company&amp;#8217;s board of directors, subject to the satisfaction of certain conditions regarding funding and ownership of the Company&amp;#8217;s capital stock, (ii) The Company and QuantumScape entered into an additional letter agreement with VGA, pursuant to which VGA will, among other things, receive an opportunity to review and comment on filings with the SEC with respect to the Proposed Transactions and be provided copies of notices provided between the parties to the QS Business Combination Agreement and (iii) The Company and QuantumScape entered into an additional letter agreement with VGA, pursuant to which QuantumScape will reserve proceeds from its Series F Preferred Stock financing and capital received through the Merger in a separate account to fund equity contributions to QSV Operations LLC.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the effective time of the Merger (the &amp;#8220;Effective Time&amp;#8221;), by virtue of the Merger and without any action on the part of the Company, Merger Sub, QuantumScape or the holders of any of QuantumScape&amp;#8217;s securities: (a) each share of QuantumScape&amp;#8217;s Class A Common Stock (which has one vote per share) and each share of QuantumScape&amp;#8217;s Preferred Stock that is convertible into QuantumScape&amp;#8217;s Class A Common Stock issued and outstanding immediately prior to the Effective Time will be canceled and converted into the right to receive the number of shares of the Company&amp;#8217;s Class A Common Stock that will be in effect after completion of the Proposed Transactions (the &amp;#8220;New Kensington Class A Common Stock&amp;#8221;) equal to the Exchange Ratio.&amp;#160;&amp;#8220;Exchange Ratio&amp;#8221; means the quotient obtained by dividing (x) the &amp;#8220;Target Share Amount&amp;#8221;, which is to be calculated in accordance with the QS Business Combination Agreement and is, as of the date of the QS Business Combination Agreement, equal to 368,799,998, by (y) the Fully-Diluted Company Shares.&amp;#160;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The New Kensington Class A Common Stock will have one vote per share; (b) each share of QuantumScape&amp;#8217;s Class B Common Stock (which has 10 votes per share) and each share of QuantumScape&amp;#8217;s Preferred Stock that is convertible into QuantumScape&amp;#8217;s Class B Common Stock issued and outstanding immediately prior to the Effective Time will be canceled and converted into the right to receive the number of shares of the Company&amp;#8217;s Class B Common Stock that will be in effect after completion of the Proposed Transactions (the &amp;#8220;New Kensington Class B Common Stock&amp;#8221;; and together with the New Kensington Class A Common Stock, the &amp;#8220;New Kensington Common Stock&amp;#8221;) equal to the Exchange Ratio.&amp;#160;The New Kensington Class B Common Stock will have ten votes per share; (c) each share of QuantumScape&amp;#8217;s Capital Stock held in the treasury of QuantumScape will be cancelled without any conversion thereof and no payment or distribution will be made with respect thereto; (d) each share of Merger Sub Common Stock issued and outstanding immediately prior to the Effective Time will be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock of the Surviving Corporation; (e) each QuantumScape Option that is outstanding immediately prior to the Effective Time, whether vested or unvested, will be converted into an option to purchase a number of shares of the applicable class of New Kensington Common Stock that the pre-conversion QuantumScape Option covers (such option, an &amp;#8220;Exchanged Option&amp;#8221;) equal to the product (rounded down to the nearest whole number) of (i)&amp;#160;the number of shares of QuantumScape&amp;#8217;s Common Stock subject to such QuantumScape Option immediately prior to the Effective Time and (ii)&amp;#160;the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&amp;#160;the exercise price per share of such Company Option immediately prior to the Effective Time divided by (B)&amp;#160;Exchange Ratio. Except as specifically provided in the QS Business Combination Agreement, following the Effective Time, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Option immediately prior to the Effective Time; (f) each share of QuantumScape&amp;#8217;s Restricted Stock that is outstanding immediately prior to the Effective Time will be converted into restricted shares of the applicable class of New Kensington Common Stock that the pre-conversion QuantumScape&amp;#8217;s Restricted Stock covers (such share of restricted Common Stock, an &amp;#8220;Exchanged Restricted Common Stock&amp;#8221;) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of QuantumScape&amp;#8217;s Restricted Stock immediately prior to the Effective Time and (ii) the Exchange Ratio.&amp;#160;Except as specifically provided above, following the Effective Time, each Exchanged Restricted Stock shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former QuantumScape&amp;#8217;s Restricted Stock immediately prior to the Effective Time; (g) each QuantumScape RSU that is outstanding immediately prior to the Effective Time shall be converted into restricted stock units of the applicable class of New Kensington Common Stock that the pre-conversion Company RSU covers (such restricted stock unit award covering Common Stock, an &amp;#8220;Exchanged RSU&amp;#8221;) equal to the product (rounded down to the nearest whole number) of (i) the number of shares subject to a QuantumScape RSU immediately prior to the Effective Time and (ii) the Exchange Ratio.&amp;#160;Except as specifically provided above, following the Effective Time, each Exchanged RSU shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former QuantumScape RSU immediately prior to the Effective Time; and (h) each QuantumScape Warrant that is outstanding immediately prior to the Effective Time will be converted into a warrant to purchase a number of shares of the applicable class of New Kensington Common Stock that corresponded to the class for which the pre-conversion QuantumScape Warrant was exercisable (such warrant, an &amp;#8220;Exchanged Warrant&amp;#8221;) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Company Common Stock subject to such QuantumScape Warrant immediately prior to the Effective Time and (ii) the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such QuantumScape Warrant immediately prior to the Effective Time divided by (B) the Exchange Ratio.&amp;#160;Except as specifically provided above, following the Effective Time, each Exchanged Warrant shall continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Warrant immediately prior to the Effective Time.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 2, 2020, the Company, Sponsor and certain stockholders of QuantumScape (the &amp;#8220;New Holders&amp;#8221; and, collectively with the Original Holder, the &amp;#8220;Holders&amp;#8221;) entered into the Registration Rights and Lock-Up Agreement, which shall be effective at the Closing. Pursuant to the terms of the Registration Rights and Lock-Up Agreement, the Company will be obligated to file a registration statement to register the resale of certain securities of the Company held by the Holders. In addition, pursuant to the terms of the Registration Rights and Lock-Up Agreement and subject to certain requirements and customary conditions, including with regard to the number of demand rights that may be exercised, the Holders may demand at any time or from time to time, that the Company file a registration statement on Form&amp;#160;S-3 (or on Form&amp;#160;S-1 if Form&amp;#160;S-3 is not available) to register the securities of the Company held by such Holders. The Registration Rights and Lock-Up Agreement also provides the Holders with &amp;#8220;piggy-back&amp;#8221; registration rights, subject to certain requirements and customary conditions.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Registration Rights and Lock-Up Agreement further provides for the securities of the Company held by the Holders to be locked-up for a period of time following the Closing, as described below, subject to certain exceptions. The securities held by the Original Holder will be locked-up for one year following the Closing, subject to earlier release if (i)&amp;#160;the reported last sale price of the Company&amp;#8217;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Closing or (ii)&amp;#160;if the Company consummates a liquidation, merger, stock exchange or other similar transaction after the Closing which results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. The securities held by the New Holders will be locked-up for 180 days after the Closing, subject to earlier release if (i)&amp;#160;the reported last sale price of the Company&amp;#8217;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Closing or (ii)&amp;#160;if the Company consummates a liquidation, merger, stock exchange or other similar transaction after the Closing which results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. &lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the execution of the QS Business Combination Agreement, effective as of September 2, 2020, the Company entered into separate subscription agreements (each, a &amp;#8220;Subscription Agreement&amp;#8221;) with a number of investors (each a &amp;#8220;Subscriber&amp;#8221;), pursuant to which the Subscribers agreed to purchase, and the Company agreed to sell to the Subscribers, an aggregate of 50,000,000 shares of the Company&amp;#8217;s Class A Common Stock (which will be New Kensington Class A Common Stock upon completion of the Proposed Transactions) (the &amp;#8220;PIPE Shares&amp;#8221;), for a purchase price of $10.00 per share and an aggregate purchase price of $500 million, in a private placement (the &amp;#8220;PIPE&amp;#8221;).&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The closing of the sale of the PIPE Shares pursuant to the Subscription Agreement is contingent upon, among other customary closing conditions, the substantially concurrent consummation of the Proposed Transactions. The purpose of the PIPE is to raise additional capital for use by the combined company following the Closing.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to the Subscription Agreements, the Company agreed, among other things, that, within 15 business days after the consummation of the Proposed Transactions, it will file with the SEC (at the Company&amp;#8217;s sole cost and expense) a registration statement registering the resale of the PIPE Shares (the &amp;#8220;Resale Registration Statement&amp;#8221;), and the Company will use its commercially reasonable efforts to have the Resale Registration Statement declared effective as soon as practicable after the filing thereof. &lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 2, 2020, the Company entered into separate Senior Employee Lock-Up Agreements with certain senior level employees of QuantumScape (the &amp;#8220;Senior Employees&amp;#8221;), including QuantumScape&amp;#8217;s executive officers.&amp;#160;The Senior Employee Lock-Up Agreements provide that the securities of the Company owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) (collectively, the &amp;#8220;Lock-Up Shares&amp;#8221;) may generally not be transferred for at least 180 days after the Closing (the &amp;#8220;Initial Lock-Up Period&amp;#8221;) and up to four years after the Closing, subject to certain exceptions.&amp;#160;Following the Initial Lock-Up Period, Senior Employees may transfer Lock-Up Shares without restriction as follows: (i) during the first year after the Effective Time, up to 25% of the total number of Lock-Up Shares, (ii) following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an event described below, up to 50% of the total number of Lock-Up Shares, and (iii) up to an additional 50% of the total number of Lock-Up Shares following satisfaction of agreed delivery requirements between QuantumScape and VGA.&amp;#160;These transfer restrictions are subject to earlier release if (a) the Company completes a liquidation, merger, stock exchange or other similar transaction after the Closing that results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property; (b) VGA terminates for any reason the Amended and Restated Joint Venture Agreement, dated as of May 14, 2020, by and among QuantumScape and VGA; (c) VGA issues a critical or negative statement regarding the Company and its technology unless such statement is required to be made by VGA under applicable law and is truthful and accurate; or (d) VGA transfers certain Company securities in excess of the amounts set forth in the Senior Employee Lock-Up Agreements.&amp;#160;The Senior Employee Lock-Up Agreements also provide that, upon consummation of the Merger, the Company or QuantumScape shall pay to each Senior Employee a one-time cash bonus equal to 20% of the Senior Employee&amp;#8217;s then annual base salary.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liquidity and Capital Resources&lt;font style="font-weight:normal;"&gt; &lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As indicated in the accompanying balance sheet, at September 30, 2020, the Company had approximately $1.0&amp;#160;million in cash, and working capital of approximately $42,000&amp;#160;(not taken into account tax obligations).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the proceeds of $25,000 from the sale of the Founders Shares (as defined in Note 4), and loan proceeds from the Sponsor of $75,000 (which is still outstanding to date) ).&amp;#160;&amp;#160;Subsequent from the consummation of the Initial Public Offering, the Company&amp;#8217;s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&amp;#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&amp;#8220;Working Capital Loans&amp;#8221;). As of September 30, 2020, there were no amounts outstanding under any Working Capital Loan.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Management has determined that the Company has access to funds from the Sponsor that are sufficient to fund the working capital needs of the Company until the consummation of an initial Business Combination or for a minimum of one year from the date of issuance of these unaudited condensed financial statements. However, in connection with the Company&amp;#8217;s assessment of going concern considerations in accordance with Financial Accounting Standards Board Accounting Standards Update 2014-15, &amp;#8220;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern,&amp;#8221; management has determined that the Company&amp;#8217;s mandatory liquidation and subsequent dissolution raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate and dissolve after June 30, 2022.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Management is currently evaluating the impact of the COVID-19 pandemic on the industry and effect on the Company&amp;#8217;s financial position, results of its operations and/or search for a target company.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 2&amp;#8212;Summary of Significant Accounting Policies&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the period from April 17, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on July 7, 2020 and June 26, 2020, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-weight:bold;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Emerging Growth Company&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is an &amp;#8220;emerging growth company,&amp;#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &amp;#8220;JOBS Act&amp;#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;This may make comparison of the Company&amp;#8217;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and marketable securities held in Trust Account&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At September 30, 2020 the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the period from April 17, 20202 (inception) through September 30, 2020, no amounts were withdrawn from the Trust Account to pay taxes.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000&lt;font style="color:#000000;"&gt;, and investments held in Trust Account&lt;/font&gt;. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;font style="color:#000000;"&gt; The Company&amp;#8217;s investments held in the Trust Account as of September 30, 2020 is comprised of &lt;/font&gt;investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities&lt;font style="color:#000000;"&gt; money market funds.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments Held in the Trust Account&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company&amp;#8217;s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0.42%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of September 30, 2020, the carrying values of cash, accounts payable, accrued expenses, franchise tax payable and income tax payable approximate their fair values due to the short-term nature of the instruments.&amp;#160;The Company&amp;#8217;s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 180 days or less or investments in a money market funds that comprise only U.S. treasury securities and are recognized at fair value.&amp;#160;The fair value of investments held in Trust Account is determined using quoted prices in active markets.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering and that were charged to additional paid-in capital upon the completion of the Initial Public Offering.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Class A common stock subject to possible redemption&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 &amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable &lt;font style="Background-color:#FFFFFF;"&gt;Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&amp;#8217;s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders&amp;#8217; equity. The Company&amp;#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020, 21,697,668 shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s balance sheet.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Loss Per Common Share&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &amp;#8220;Earnings Per Share.&amp;#8221; Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. &lt;font style="Background-color:#FFFFFF;"&gt;Through June 30, 2020, the date the underwriters exercised in full their over-allotment option, w&lt;/font&gt;&lt;font style="color:#000000;"&gt;eighted average shares were reduced for the effect of an aggregate of 750,000 shares of common stock that were subject to forfeiture.&lt;/font&gt;&lt;font style="Background-color:#FFFFFF;"&gt; An aggregate of 21,697,668 shares of Class A common stock subject to possible redemption at September 30, 2020 has been excluded from the calculation of basic loss per share of common stock, since such shares, if redeemed, only participate in their pro rata share of the trust earnings. The Company has not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-Allotment Units) and Private Placement to purchase an aggregate of 18,074,992 shares of the Company&amp;#8217;s common stock in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reconciliation of Net Loss per Common Share&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s net loss is adjusted for the portion of income (loss) that is attributable to Class A common stock subject to redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Three&amp;#160;Months&amp;#160;Ended&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Period&amp;#160;From&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;April 17, 2020&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(inception)&amp;#160;through&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.02%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,462,589&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Income attributable to Class A ordinary shares&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; subject to possible redemption&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,183&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Adjusted net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,438,406&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average ordinary shares outstanding, basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,053,922&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,248,452&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.24&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, &amp;#8220;Income Taxes.&amp;#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2020.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security &amp;#8220;CARES&amp;#8221; Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (&amp;#8220;NOL&amp;#8221;) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company's financial position or statement of operations.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Standards&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted would have a material effect on the accompanying &lt;font style="Background-color:#FFFFFF;"&gt;financial statements&lt;/font&gt;.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<kcac:InitialPublicOfferingDisclosureTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 3&amp;#8212;Initial Public Offering&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="Background-color:#FFFFFF;"&gt;On June 30, 2020, the Company sold 23,000,000 Units, including 3,000,000 Over-Allotment Units, at a price of $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.1 million, inclusive of approximately $8.1 million in deferred underwriting commissions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (each, a &amp;#8220;Public Warrant&amp;#8221;). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 6).&lt;/p&gt;</kcac:InitialPublicOfferingDisclosureTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 4&amp;#8212;Related Party Transactions&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Founder Shares&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On April 17, 2020, the Sponsor subscribed to purchase 5,031,250 shares of the Company&amp;#8217;s Class B common stock, par value $0.0001 per share (the &amp;#8220;Founder Shares&amp;#8221;), and fully paid for those shares on June 30, 2020. On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and associated amounts have been retroactively restated to reflect the share capitalization. The initial stockholders agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters so that the Founder Shares represented 20.0% of the Company&amp;#8217;s issued and outstanding shares of common stock after the Initial Public Offering.&amp;nbsp;&amp;nbsp;&lt;font style="Background-color:#FFFFFF;"&gt;The underwriter exercised its over-allotment option in full on June 30, 2020; thus, the 750,000 Founder Shares were no longer subject to forfeiture.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: &lt;font style="color:#231F20;"&gt;(A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Private Placement Warrants&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="Background-color:#FFFFFF;"&gt;Simultaneously with the closing of the Initial Public Offering, the Company sold &lt;/font&gt;6,575,000 &lt;font style="Background-color:#FFFFFF;"&gt;Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds of approximately $6.6 million.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (except as described below) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the Private Placement Warrants until 30 days after the completion of the initial Business Combination.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Related Party Loans&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On April 17, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &amp;#8220;Note&amp;#8221;). This loan is non-interest bearing and payable upon the completion of the Initial Public Offering. As of September 30, 2020, the Company has borrowed $75,000 under the Note.&amp;nbsp;&amp;nbsp;To date, the balance of the Note remains outstanding.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&amp;#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&amp;#8220;Working Capital Loans&amp;#8221;). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender&amp;#8217;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Service and Administrative Fees&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has agreed to pay service and administrative fees of $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the Company&amp;#8217;s Chief Financial Officer, for up to 18 months commencing on the date of consummation of the Initial Public Offering. &lt;font style="Background-color:#FFFFFF;"&gt;As of September 30, 2020, the Company incurred $80,000 in general and administrative expenses in the accompanying condensed consolidated statement of operations and no amounts were payable in the accompanying balance sheet in connection with such services.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&amp;#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company&amp;#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers, directors or their affiliates.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 5&amp;#8212;Commitments &amp;amp; Contingencies&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Registration Rights&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares will be entitled to registration rights pursuant to a registration rights. These holders will be entitled to certain demand and &amp;#8220;piggyback&amp;#8221; registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Underwriting Agreement&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $8.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 6&amp;#8212;Stockholders&amp;#8217; Equity&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Preferred Stock&lt;font style="font-weight:normal;font-style:normal;"&gt;&amp;#8212;The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company&amp;#8217;s board of directors. As of September 30, 2020, there were no shares of preferred stock issued or outstanding.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Class A Common Stock&lt;font style="font-weight:normal;font-style:normal;"&gt;&amp;#8212;The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2020, &lt;/font&gt;&lt;font style="Background-color:#FFFFFF;font-weight:normal;font-style:normal;"&gt;there were 23,000,000 shares of Class A common stock issued or outstanding, including &lt;/font&gt;&lt;font style="font-weight:normal;font-style:normal;"&gt;21,697,668&lt;/font&gt;&lt;font style="Background-color:#FFFFFF;font-weight:normal;font-style:normal;"&gt; shares of Class A common stock subject to possible redemption, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Class B Common Stock&lt;font style="font-weight:normal;font-style:normal;"&gt;&amp;#8212;The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. On April 17, 2020, the Sponsor subscribed to purchase 5,031,250 shares of Class B common stock, which was fully paid on June 30, 2020. On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and associated amounts have been retroactively restated to reflect the share capitalization. Of these, an aggregate of up to 750,000 shares of Class B common stock that were subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters&amp;#8217; over-allotment option is not exercised in full or in part, so that the number of Founder Shares equals 20% of the Company&amp;#8217;s issued and outstanding shares of common stock after the Initial Public Offering.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;font style="Background-color:#FFFFFF;font-weight:normal;font-style:normal;"&gt;The underwriter exercised its over-allotment option in full on June 30, 2020; thus, the 750,000 Founder Shares were no longer subject to forfeiture.&lt;/font&gt; As a result, as of September 30, 2020, 5,750,000 Class B common stock was issued and outstanding. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders; provided that, prior to the completion of the initial Business Combination, holders of the Class B common stock will have the right to elect all of the Company&amp;#8217;s directors and remove members of the Company&amp;#8217;s board of directors for any reason. Prior to the completion of the initial Business Combination, only holders of the Class B common stock will have the right to vote on the Company&amp;#8217;s election of directors. Holders of the Public Shares will not be entitled to vote on the Company&amp;#8217;s election of directors during such time. In addition, prior to the completion of the initial Business Combination, holders of a majority of the outstanding shares of the Class B common stock may remove a member of the Company&amp;#8217;s board of directors for any reason. These provisions of the Certificate of Incorporation may only be amended by a resolution passed by the holders of a majority of shares of the Class B common stock. With respect to any other matter submitted to a vote of the Company&amp;#8217;s stockholders, including any vote in connection with the initial Business Combination, holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&amp;#8217;s stockholders, except as required by law.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination, or earlier at the option of the holders, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Offering and related to the closing of the initial Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued or issuable to any seller in the initial Business Combination).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Warrants&lt;font style="font-weight:normal;font-style:normal;"&gt;&amp;#8212;Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed; provided, that if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &amp;#8220;covered security&amp;#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &amp;#8220;cashless basis&amp;#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The warrants have an exercise price of $11.50 per share. If (x) the Company issue additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue price to be determined in good faith by the Company&amp;#8217;s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the &amp;#8220;Newly Issued Price&amp;#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&amp;#8217;s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the &amp;#8220;Market Value&amp;#8221;) is below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Private Placement Warrants are identical to the Public Warrants, except that (1) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants are be non-redeemable (except as described below) so long as they are held by the Sponsor or its permitted transferees, (3) the Private Placement Warrants may be exercised by the holders on a cashless basis and (4) the holders of the Private Placement Warrants (including with respect to the shares of common stock issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company may call the Public Warrants for redemption:&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;color:#000000;"&gt;in whole and not in part;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;color:#000000;"&gt;at a price of $0.01 per warrant;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;color:#000000;"&gt;upon a minimum of 30 days&amp;#8217; prior written notice of redemption; and&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;color:#000000;"&gt;if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &amp;#8220;cashless basis,&amp;#8221; as described in the warrant agreement.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants:&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;"&gt;in whole and not in part;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;"&gt;at $0.10 per warrant upon a minimum of 30 days&amp;#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to a table in the warrant agreement;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;"&gt;if, and only if, the last reported sale price of the Company&amp;#8217;s Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;"&gt;if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;"&gt;if, and only if, there is an effective registration statement covering the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in the initial Business Combination) issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&amp;#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 7&amp;#8212;Fair Value Measurements&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the Company&amp;#8217;s financial assets and liabilities reflects management&amp;#8217;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:86.67%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:80%;"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Times New Roman';font-size:15pt;line-height:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:86.67%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:80%;"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Times New Roman';font-size:15pt;line-height:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:86.67%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:3.33%;"&gt;&lt;/td&gt;
&lt;td style="width:80%;"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:'Times New Roman';font-size:15pt;line-height:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;font style="font-size:10pt;font-family:'Times New Roman'"&gt;&amp;#8226;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3: Unobservable inputs based on the Company&amp;#8217;s assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%; border-top:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%; border-top:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,075,599&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 8&amp;#8212;Subsequent Events&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On October 2, 2020, a putative class action lawsuit was filed against the Company. The complaint names the Company and certain members of the Company&amp;#8217;s board as defendants. The complaint alleges, among other things, breach of fiduciary duty claims in connection with the proposed business combination with QuantumScape Corporation. Management with its legal counsel are currently evaluating the merits of the complaint and as of September 30, 2020, the Company had not accrued any amounts for this contingency.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The special meeting of the Company&amp;#8217;s stockholders to approve the Business Combination with QuantumScape is scheduled to occur on November 25, 2020.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:UseOfEstimates contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the period from April 17, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on July 7, 2020 and June 26, 2020, respectively.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<kcac:EmergingGrowthCompanyPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Emerging Growth Company&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is an &amp;#8220;emerging growth company,&amp;#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &amp;#8220;JOBS Act&amp;#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;This may make comparison of the Company&amp;#8217;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</kcac:EmergingGrowthCompanyPolicyTextBlock>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<kcac:CashAndMarketableSecuritiesHeldInTrustAccountPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and marketable securities held in Trust Account&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At September 30, 2020 the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the period from April 17, 20202 (inception) through September 30, 2020, no amounts were withdrawn from the Trust Account to pay taxes.&lt;/p&gt;</kcac:CashAndMarketableSecuritiesHeldInTrustAccountPolicyTextBlock>
	<us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000&lt;font style="color:#000000;"&gt;, and investments held in Trust Account&lt;/font&gt;. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;font style="color:#000000;"&gt; The Company&amp;#8217;s investments held in the Trust Account as of September 30, 2020 is comprised of &lt;/font&gt;investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities&lt;font style="color:#000000;"&gt; money market funds.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
	<kcac:InvestmentsHeldInTrustAccountPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments Held in the Trust Account&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company&amp;#8217;s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;</kcac:InvestmentsHeldInTrustAccountPolicyTextBlock>
	<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0.42%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div align="left"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;"&gt;&amp;#x2022;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of September 30, 2020, the carrying values of cash, accounts payable, accrued expenses, franchise tax payable and income tax payable approximate their fair values due to the short-term nature of the instruments.&amp;#160;The Company&amp;#8217;s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 180 days or less or investments in a money market funds that comprise only U.S. treasury securities and are recognized at fair value.&amp;#160;The fair value of investments held in Trust Account is determined using quoted prices in active markets.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
	<kcac:OfferingCostsPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering and that were charged to additional paid-in capital upon the completion of the Initial Public Offering.&lt;/p&gt;</kcac:OfferingCostsPolicyTextBlock>
	<us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Class A common stock subject to possible redemption&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 &amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable &lt;font style="Background-color:#FFFFFF;"&gt;Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&amp;#8217;s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders&amp;#8217; equity. The Company&amp;#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020, 21,697,668 shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s balance sheet.&lt;/font&gt;&lt;/p&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Loss Per Common Share&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &amp;#8220;Earnings Per Share.&amp;#8221; Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. &lt;font style="Background-color:#FFFFFF;"&gt;Through June 30, 2020, the date the underwriters exercised in full their over-allotment option, w&lt;/font&gt;&lt;font style="color:#000000;"&gt;eighted average shares were reduced for the effect of an aggregate of 750,000 shares of common stock that were subject to forfeiture.&lt;/font&gt;&lt;font style="Background-color:#FFFFFF;"&gt; An aggregate of 21,697,668 shares of Class A common stock subject to possible redemption at September 30, 2020 has been excluded from the calculation of basic loss per share of common stock, since such shares, if redeemed, only participate in their pro rata share of the trust earnings. The Company has not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-Allotment Units) and Private Placement to purchase an aggregate of 18,074,992 shares of the Company&amp;#8217;s common stock in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reconciliation of Net Loss per Common Share&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s net loss is adjusted for the portion of income (loss) that is attributable to Class A common stock subject to redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Three&amp;#160;Months&amp;#160;Ended&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Period&amp;#160;From&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;April 17, 2020&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(inception)&amp;#160;through&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.02%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,462,589&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Income attributable to Class A ordinary shares&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; subject to possible redemption&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,183&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Adjusted net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,438,406&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average ordinary shares outstanding, basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,053,922&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,248,452&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.24&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, &amp;#8220;Income Taxes.&amp;#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2020.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security &amp;#8220;CARES&amp;#8221; Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (&amp;#8220;NOL&amp;#8221;) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company's financial position or statement of operations.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Standards&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted would have a material effect on the accompanying &lt;font style="Background-color:#FFFFFF;"&gt;financial statements&lt;/font&gt;.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&amp;#8217;s net loss is adjusted for the portion of income (loss) that is attributable to Class A common stock subject to redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Three&amp;#160;Months&amp;#160;Ended&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.34%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For&amp;#160;The&amp;#160;Period&amp;#160;From&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;April 17, 2020&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(inception)&amp;#160;through&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.02%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,462,589&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Income attributable to Class A ordinary shares&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; subject to possible redemption&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,183&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Adjusted net loss&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,438,406&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,525,451&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average ordinary shares outstanding, basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp; and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,053,922&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,248,452&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.02%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.34%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.24&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="C_0001811414_20200417_20200930">
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%; border-top:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%; border-top:solid 0.75pt #000000;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.26%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.36%;"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,075,599&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200628_20200630" decimals="INF" unitRef="xbrli_shares">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200628_20200630" decimals="INF" unitRef="xbrli_shares">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockPricePerShare contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630" decimals="INF" unitRef="iso4217_USD_xbrli_shares">10.00</us-gaap:SaleOfStockPricePerShare>
	<us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200628_20200630" decimals="-5" unitRef="iso4217_USD">230000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
	<us-gaap:PaymentsOfStockIssuanceCosts contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200628_20200630" decimals="-5" unitRef="iso4217_USD">13100000</us-gaap:PaymentsOfStockIssuanceCosts>
	<kcac:PaymentOfDeferredUnderwritingCommissions contextRef="C_0001811414_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200628_20200630" decimals="-5" unitRef="iso4217_USD">8100000</kcac:PaymentOfDeferredUnderwritingCommissions>
	<kcac:ClassOfWarrantsOrRightsIssued contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200628_20200630" decimals="INF" unitRef="xbrli_shares">6575000</kcac:ClassOfWarrantsOrRightsIssued>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200630" decimals="INF" unitRef="iso4217_USD_xbrli_shares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ProceedsFromIssuanceOfWarrants contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200628_20200630" decimals="-5" unitRef="iso4217_USD">6600000</us-gaap:ProceedsFromIssuanceOfWarrants>
	<us-gaap:AssetsHeldInTrustNoncurrent contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630" decimals="-5" unitRef="iso4217_USD">230000000</us-gaap:AssetsHeldInTrustNoncurrent>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200630" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<kcac:MaximumNetTangibleAssetsForBusinessCombination contextRef="C_0001811414_20200630" decimals="INF" unitRef="iso4217_USD">5000001</kcac:MaximumNetTangibleAssetsForBusinessCombination>
	<us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="C_0001811414_20200630" decimals="INF" unitRef="iso4217_USD_xbrli_shares">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
	<kcac:PercentageOfPublicSharesToBeRedeemed contextRef="C_0001811414_20200628_20200630" decimals="INF" unitRef="xbrli_pure">1.00</kcac:PercentageOfPublicSharesToBeRedeemed>
	<kcac:InterestToPayDissolutionExpenses contextRef="C_0001811414_20200628_20200630" decimals="0" unitRef="iso4217_USD">100000</kcac:InterestToPayDissolutionExpenses>
	<kcac:BusinessCombinationExchangeRatio contextRef="C_0001811414_20200902_20200902" decimals="10" unitRef="xbrli_pure">4.0032186234</kcac:BusinessCombinationExchangeRatio>
	<us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacExchangedWarrantsMember_20200902" decimals="INF" unitRef="xbrli_shares">368799998</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
	<kcac:AggregatePurchasePricePerShare contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902" decimals="2" unitRef="iso4217_USD_xbrli_shares">10.00</kcac:AggregatePurchasePricePerShare>
	<kcac:CommonStockVotingRightsVotesPerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200902_20200902" decimals="INF" unitRef="kcac_Vote">1</kcac:CommonStockVotingRightsVotesPerShare>
	<kcac:BusinessCombinationCommonStockRightToReceiveNumberOfShares contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200902" decimals="INF" unitRef="xbrli_shares">368799998</kcac:BusinessCombinationCommonStockRightToReceiveNumberOfShares>
	<kcac:CommonStockVotingRightsVotesPerShare contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200902_20200902" decimals="INF" unitRef="kcac_Vote">10</kcac:CommonStockVotingRightsVotesPerShare>
	<kcac:LockedUpPeriod contextRef="C_0001811414_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">P1Y</kcac:LockedUpPeriod>
	<kcac:LockedUpPeriod contextRef="C_0001811414_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">P180D</kcac:LockedUpPeriod>
	<us-gaap:SharePrice contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902" decimals="2" unitRef="iso4217_USD_xbrli_shares">12.00</us-gaap:SharePrice>
	<us-gaap:SharePrice contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902" decimals="2" unitRef="iso4217_USD_xbrli_shares">12.00</us-gaap:SharePrice>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">P20D</kcac:NumberOfTradingDays>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">P20D</kcac:NumberOfTradingDays>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">P30D</kcac:NumberOfTradingDays>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">P30D</kcac:NumberOfTradingDays>
	<kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacOriginalHolderMember_20200902_20200902">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
	<kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapDistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_kcacNewHoldersMember_20200902_20200902">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
	<kcac:AggregateNumberOfSharesSold contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902" decimals="INF" unitRef="xbrli_shares">50000000</kcac:AggregateNumberOfSharesSold>
	<kcac:AggregatePurchasePricePerShare contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902" decimals="INF" unitRef="iso4217_USD_xbrli_shares">10.00</kcac:AggregatePurchasePricePerShare>
	<kcac:AggregatePurchasePrice contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20200902_20200902" decimals="-6" unitRef="iso4217_USD">500000000</kcac:AggregatePurchasePrice>
	<kcac:NumberOfBusinessDays contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSubscriptionAgreementMember_20200902_20200902">P15D</kcac:NumberOfBusinessDays>
	<kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902">P180D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
	<kcac:InitialLockUpPeriodAfterClosingSubjectToCertainExpectations contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902">P4Y</kcac:InitialLockUpPeriodAfterClosingSubjectToCertainExpectations>
	<kcac:PercentageOfFirstYearAfterEffectiveLockUpShares contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902" decimals="2" unitRef="xbrli_pure">0.25</kcac:PercentageOfFirstYearAfterEffectiveLockUpShares>
	<kcac:PercentageOfFourYearAfterClosingLockUpShares contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902" decimals="2" unitRef="xbrli_pure">0.50</kcac:PercentageOfFourYearAfterClosingLockUpShares>
	<kcac:PercentageOfAdditionalFourYearAfterClosingLockUpShares contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902" decimals="2" unitRef="xbrli_pure">0.50</kcac:PercentageOfAdditionalFourYearAfterClosingLockUpShares>
	<kcac:OneTimeCashBonusPercentageOfAnnualBaseSalary contextRef="C_0001811414_us-gaapFinancialInstrumentAxis_kcacSeniorEmployeeLockUpAgreementsMember_20200902_20200902" decimals="2" unitRef="xbrli_pure">0.20</kcac:OneTimeCashBonusPercentageOfAnnualBaseSalary>
	<kcac:ProceedsFromSaleOfFoundersShares contextRef="C_0001811414_20200929_20200930" decimals="0" unitRef="iso4217_USD">25000</kcac:ProceedsFromSaleOfFoundersShares>
	<us-gaap:ProceedsFromRelatedPartyDebt contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200929_20200930" decimals="0" unitRef="iso4217_USD">75000</us-gaap:ProceedsFromRelatedPartyDebt>
	<kcac:WorkingCapital contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">42000</kcac:WorkingCapital>
	<us-gaap:LineOfCredit contextRef="C_0001811414_us-gaapDebtInstrumentAxis_kcacWorkingCapitalLoansMember_20200930" decimals="INF" unitRef="iso4217_USD">0</us-gaap:LineOfCredit>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="C_0001811414_20200930" decimals="INF" unitRef="iso4217_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
	<kcac:CashWithdrawFromTrustAccount contextRef="C_0001811414_20200417_20200930" decimals="INF" unitRef="iso4217_USD">0</kcac:CashWithdrawFromTrustAccount>
	<kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">250000</kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit>
	<kcac:InvestmentSecuritiesMaturityPeriod contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_us-gaapUSTreasurySecuritiesMember_20200417_20200930">P185D</kcac:InvestmentSecuritiesMaturityPeriod>
	<kcac:InvestmentSecuritiesMaturityPeriod contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapFinancialInstrumentAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20200417_20200930">P185D</kcac:InvestmentSecuritiesMaturityPeriod>
	<us-gaap:TemporaryEquitySharesOutstanding contextRef="C_0001811414_us-gaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200930" decimals="INF" unitRef="xbrli_shares">21697668</us-gaap:TemporaryEquitySharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation contextRef="C_0001811414_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_kcacUnderwritersSharesMember_20200417_20200930" decimals="0" unitRef="xbrli_shares">750000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C_0001811414_us-gaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_kcacClassACommonStockSubjectToMandatoryRedemptionMember_20200417_20200930" decimals="0" unitRef="xbrli_shares">21697668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C_0001811414_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200417_20200930" decimals="0" unitRef="xbrli_shares">18074992</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">-24183</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="iso4217_USD">-1438406</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="iso4217_USD">-1525451</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="C_0001811414_20200701_20200930" decimals="0" unitRef="xbrli_shares">7053922</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="C_0001811414_20200417_20200930" decimals="0" unitRef="xbrli_shares">6248452</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:UnrecognizedTaxBenefits contextRef="C_0001811414_20200930" decimals="INF" unitRef="iso4217_USD">0</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="C_0001811414_20200930" decimals="INF" unitRef="iso4217_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<kcac:DescriptionOfPublicWarrant contextRef="C_0001811414_20200417_20200930">Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant.</kcac:DescriptionOfPublicWarrant>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
	<us-gaap:SharePrice contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">11.50</us-gaap:SharePrice>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200417" decimals="INF" unitRef="xbrli_shares">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200417_20200417" decimals="INF" unitRef="xbrli_shares">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
	<kcac:PercentageOfSharesIssuedAndOutstanding contextRef="C_0001811414_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200417_20200417" decimals="INF" unitRef="xbrli_pure">0.200</kcac:PercentageOfSharesIssuedAndOutstanding>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="C_0001811414_srtTitleOfIndividualAxis_kcacFounderMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200417_20200630" decimals="INF" unitRef="xbrli_shares">750000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:SharePrice contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">12.00</us-gaap:SharePrice>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200930">P20D</kcac:NumberOfTradingDays>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200930">P30D</kcac:NumberOfTradingDays>
	<kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="C_0001811414_srtRangeAxis_srtMinimumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_20200417_20200930">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
	<kcac:ClassOfWarrantsOrRightsIssued contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200417_20200930" decimals="INF" unitRef="xbrli_shares">6575000</kcac:ClassOfWarrantsOrRightsIssued>
	<kcac:ClassOfWarrantsOrRightsIssuePrice contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">1.00</kcac:ClassOfWarrantsOrRightsIssuePrice>
	<us-gaap:ProceedsFromIssuanceOfWarrants contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200417_20200930" decimals="-5" unitRef="iso4217_USD">6600000</us-gaap:ProceedsFromIssuanceOfWarrants>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200930" decimals="INF" unitRef="xbrli_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_kcacPrivatePlacementWarrantsMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination contextRef="C_0001811414_20200417_20200930">P30D</kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination>
	<us-gaap:DebtInstrumentFaceAmount contextRef="C_0001811414_us-gaapDebtInstrumentAxis_kcacPromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200417" decimals="INF" unitRef="iso4217_USD">300000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="C_0001811414_us-gaapDebtInstrumentAxis_kcacPromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200630" decimals="0" unitRef="iso4217_USD">75000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="C_0001811414_us-gaapDebtInstrumentAxis_kcacWorkingCapitalLoansMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200417_20200930" decimals="0" unitRef="iso4217_USD">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C_0001811414_us-gaapDebtInstrumentAxis_kcacWorkingCapitalLoansMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200417_20200930" decimals="0" unitRef="iso4217_USD">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
	<kcac:PeriodOfService contextRef="C_0001811414_srtTitleOfIndividualAxis_srtChiefFinancialOfficerMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200417_20200930">P18M</kcac:PeriodOfService>
	<us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200417_20200930" decimals="0" unitRef="iso4217_USD">80000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
	<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtAffiliatedEntityMember_20200930" decimals="0" unitRef="iso4217_USD">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
	<kcac:UnderwritingDiscountPerUnit contextRef="C_0001811414_20200930" decimals="2" unitRef="iso4217_USD_xbrli_shares">0.20</kcac:UnderwritingDiscountPerUnit>
	<us-gaap:PaymentsForUnderwritingExpense contextRef="C_0001811414_20200417_20200930" decimals="-5" unitRef="iso4217_USD">4600000</us-gaap:PaymentsForUnderwritingExpense>
	<kcac:DeferredUnderwritingCommissionPerUnit contextRef="C_0001811414_20200930" decimals="2" unitRef="iso4217_USD_xbrli_shares">0.35</kcac:DeferredUnderwritingCommissionPerUnit>
	<kcac:CommonStockSharesIssuedIncludingRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">23000000</kcac:CommonStockSharesIssuedIncludingRedemption>
	<kcac:CommonStockSharesOutstandingIncludingRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="xbrli_shares">23000000</kcac:CommonStockSharesOutstandingIncludingRedemption>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200417" decimals="INF" unitRef="xbrli_shares">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:CommonStockSharesOutstanding contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625" decimals="INF" unitRef="xbrli_shares">5750000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200701_20200930" decimals="INF" unitRef="xbrli_shares">750000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200625_20200625" decimals="INF" unitRef="xbrli_shares">750000</kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart>
	<kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625_20200625" decimals="2" unitRef="xbrli_pure">0.20</kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding>
	<kcac:CommonStockSharesIssuedIncludingRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="xbrli_shares">5750000</kcac:CommonStockSharesIssuedIncludingRedemption>
	<kcac:CommonStockSharesOutstandingIncludingRedemption contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200930" decimals="INF" unitRef="xbrli_shares">5750000</kcac:CommonStockSharesOutstandingIncludingRedemption>
	<us-gaap:StockholdersEquityNoteStockSplit contextRef="C_0001811414_20200701_20200930">The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination, or earlier at the option of the holders, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein.</us-gaap:StockholdersEquityNoteStockSplit>
	<kcac:PublicWarrantsExpirationTerm contextRef="C_0001811414_20200701_20200930">P5Y</kcac:PublicWarrantsExpirationTerm>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C_0001811414_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="C_0001811414_20200701_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930">P20D</kcac:NumberOfTradingDays>
	<us-gaap:BusinessAcquisitionSharePrice contextRef="C_0001811414_srtRangeAxis_srtMaximumMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">9.20</us-gaap:BusinessAcquisitionSharePrice>
	<kcac:PercentageOfProceedsFromShareIssuances contextRef="C_0001811414_20200701_20200930" decimals="2" unitRef="xbrli_pure">0.60</kcac:PercentageOfProceedsFromShareIssuances>
	<kcac:ExercisePriceAdjustmentPercentage contextRef="C_0001811414_20200701_20200930" decimals="2" unitRef="xbrli_pure">1.15</kcac:ExercisePriceAdjustmentPercentage>
	<kcac:RedemptionTriggerPriceAdjustmentPercentage contextRef="C_0001811414_20200701_20200930" decimals="2" unitRef="xbrli_pure">1.80</kcac:RedemptionTriggerPriceAdjustmentPercentage>
	<kcac:WarrantsRedemptionPricePerShare contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.01</kcac:WarrantsRedemptionPricePerShare>
	<kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
	<kcac:NumberOfTradingDays contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200701_20200930">P20D</kcac:NumberOfTradingDays>
	<kcac:NumberOfTradingDaysEndingOnThirdBusinessDay contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPrivatePlacementWarrantsMember_20200701_20200930">P30D</kcac:NumberOfTradingDaysEndingOnThirdBusinessDay>
	<kcac:WarrantsRedemptionPricePerShare contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPublicWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">0.10</kcac:WarrantsRedemptionPricePerShare>
	<kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="C_0001811414_us-gaapClassOfWarrantOrRightAxis_kcacPublicWarrantsMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassAMember_20200701_20200930" decimals="INF" unitRef="iso4217_USD_xbrli_shares">10.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
	<kcac:InvestmentsHeldInTrustAccountFairValueDisclosure contextRef="C_0001811414_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_20200930" decimals="0" unitRef="iso4217_USD">230075599</kcac:InvestmentsHeldInTrustAccountFairValueDisclosure>
	<us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
	<kcac:FairValueAssetsLevel1ToLevel3TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</kcac:FairValueAssetsLevel1ToLevel3TransfersAmount>
	<us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
	<kcac:FairValueAssetsLevel2ToLevel3TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</kcac:FairValueAssetsLevel2ToLevel3TransfersAmount>
	<kcac:FairValueAssetsLevel3ToLevel1TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</kcac:FairValueAssetsLevel3ToLevel1TransfersAmount>
	<kcac:FairValueAssetsLevel3ToLevel2TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</kcac:FairValueAssetsLevel3ToLevel2TransfersAmount>
	<us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount>
	<kcac:FairValueLiabilitiesLevel1ToLevel3TransfersAmount contextRef="C_0001811414_20200930" decimals="0" unitRef="iso4217_USD">0</kcac:FairValueLiabilitiesLevel1ToLevel3TransfersAmount>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
		<link:loc xlink:type="locator" xlink:href="#F_000086_10-Q" xlink:label="F_000086_lbl_10-Q"/>
		<link:footnote xlink:type="resource" xlink:label="FNT_000000_10-Q" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">This number excludes an aggregate of up to 21,697,668 shares of Class A common stock subject to possible redemption (Note 6).</link:footnote>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="F_000086_lbl_10-Q" xlink:to="FNT_000000_10-Q"/>
		<link:loc xlink:type="locator" xlink:href="#F_000087_10-Q" xlink:label="F_000087_lbl_10-Q"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="F_000087_lbl_10-Q" xlink:to="FNT_000000_10-Q"/>
    <link:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004_S-4_A" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004_S-4_A" xlink:type="locator"/>
    <link:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003_S-4_A" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003_S-4_A" xlink:type="locator"/>
    <link:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003_S-4_A" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003_S-4_A" xlink:type="locator"/>
    <link:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003_S-4_A" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003_S-4_A" xlink:type="locator"/>
    <link:loc xlink:href="#id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22_S-4_A" xlink:label="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22_S-4_A" xlink:type="locator"/>
    <link:loc xlink:href="#id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2_S-4_A" xlink:label="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2_S-4_A" xlink:type="locator"/>
    <link:footnote xlink:label="footnote_1078024047_S-4_A" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</link:footnote>
    <link:footnote xlink:label="footnote_1078024052_S-4_A" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</link:footnote>
    <link:footnote xlink:label="footnote_1078024057_S-4_A" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number excludes an aggregate of up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</link:footnote>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004_S-4_A" xlink:to="footnote_1078024047_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003_S-4_A" xlink:to="footnote_1078024047_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003_S-4_A" xlink:to="footnote_1078024047_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003_S-4_A" xlink:to="footnote_1078024047_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22_S-4_A" xlink:to="footnote_1078024047_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2_S-4_A" xlink:to="footnote_1078024052_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <link:footnoteArc xlink:from="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2_S-4_A" xlink:to="footnote_1078024057_S-4_A" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
	</link:footnoteLink>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="xbrli_shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="xbrli_shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="xbrli_shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">22500</us-gaap:StockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">24425</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="INF">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">86500</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">-2500</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF">0</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:PreferredStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:AssetsCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:AssetsCurrent>
  <us-gaap:Assets contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">86500</us-gaap:Assets>
  <us-gaap:Cash contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:Cash>
  <us-gaap:DeferredCosts contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">61500</us-gaap:DeferredCosts>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">64000</us-gaap:LiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">64000</us-gaap:AccruedLiabilitiesCurrent>
  <kcac:WorkingCapital contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">39000</kcac:WorkingCapital>
  <kcac:UnderwritingDiscountPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="2">0.20</kcac:UnderwritingDiscountPerUnit>
  <kcac:DeferredUnderwritingCommissionPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="2">0.35</kcac:DeferredUnderwritingCommissionPerUnit>
  <kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">250000</kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit>
  <kcac:MaximumNetTangibleAssetsForBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF">5000001</kcac:MaximumNetTangibleAssetsForBusinessCombination>
  <kcac:PricePerPrivatePlacementWarrant contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="INF">1.00</kcac:PricePerPrivatePlacementWarrant>
  <kcac:DeferredUnderwritingCommissionsPayable contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0">7000000</kcac:DeferredUnderwritingCommissionsPayable>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4071742x4263611_4078716x4078717" unitRef="iso4217_USD" decimals="0">75000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_xbrli_shares" decimals="INF">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <kcac:ClassOfWarrantsOrRightsIssuePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_xbrli_shares" decimals="INF">1.00</kcac:ClassOfWarrantsOrRightsIssuePrice>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">12.00</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4076805" unitRef="iso4217_USD" decimals="0">-2500</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4082574" unitRef="iso4217_USD" decimals="0">24425</us-gaap:StockholdersEquity>
  <us-gaap:BusinessAcquisitionSharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4070963x4072861" unitRef="iso4217_USD_xbrli_shares" decimals="INF">9.20</us-gaap:BusinessAcquisitionSharePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621" unitRef="iso4217_USD_xbrli_shares" decimals="INF">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:LineOfCredit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621" unitRef="iso4217_USD" decimals="INF">0</us-gaap:LineOfCredit>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717" unitRef="iso4217_USD_xbrli_shares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717_4082399x4078608" unitRef="xbrli_shares" decimals="INF">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <kcac:DeferredUnderwritingCommissionsNoncurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4260553" unitRef="iso4217_USD" decimals="0">8050000</kcac:DeferredUnderwritingCommissionsNoncurrent>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4268695" unitRef="iso4217_USD_xbrli_shares" decimals="INF">0.01</kcac:WarrantsRedemptionPricePerShare>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">0.10</kcac:WarrantsRedemptionPricePerShare>
  <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="xbrli_shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="xbrli_shares" decimals="INF">0</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="xbrli_shares" decimals="INF">0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">11.50</us-gaap:SharePrice>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD_xbrli_shares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="xbrli_shares" decimals="INF">10000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="xbrli_shares" decimals="INF">5750000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="xbrli_shares" decimals="INF">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD" decimals="0">575</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22_S-4_A">575</us-gaap:CommonStockValue>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4085460x4085461" unitRef="iso4217_USD" decimals="0">75000</us-gaap:DueToRelatedPartiesCurrent>
  <kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200417_20200417" unitRef="xbrli_pure" decimals="2">0.20</kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding>
  <kcac:InterestToPayDissolutionExpenses contextRef="eol_PE1119467-20S-4-0005_STD_1_20200501_0" unitRef="iso4217_USD" decimals="INF">100000</kcac:InterestToPayDissolutionExpenses>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="C_0001811414_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_kcacSponsorMember_us-gaapStatementClassOfStockAxis_us-gaapCommonClassBMember_20200625_20200625" unitRef="xbrli_shares" decimals="INF">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:CommonStockDividendsShares contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461" unitRef="xbrli_shares" decimals="INF">718750</us-gaap:CommonStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461" unitRef="xbrli_shares" decimals="INF">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4070963x4072861_4078716x4078721_4078739x4405944_4085460x4085461" unitRef="xbrli_shares" decimals="INF">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&amp;#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">4000000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="INF">750000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:ProfitLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">2500</us-gaap:ProfitLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="0" id="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2_S-4_A">5000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">25000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">2500</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 4&amp;#x2014;Related Party Transactions&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&amp;#xA0;shares of the Company&amp;#x2019;s Class&amp;#xA0;B common
 stock, par value $0.0001 per share (the &amp;#x201C;Founder
 Shares&amp;#x201D;), and fully paid for those shares on May&amp;#xA0;1,
 2020. On June&amp;#xA0;25, 2020, the Company effected a stock dividend
 with respect to the Class&amp;#xA0;B common stock, resulting in the
 Sponsor holding an aggregate of 5,750,000 founder shares. All
 shares and associated amounts have been retroactively restated to
 reflect the share capitalization. The initial stockholders have
 agreed to forfeit up to 750,000 Founder Shares to the extent that
 the over-allotment&amp;#xA0;option is not exercised in full by the
 underwriters. The forfeiture will be adjusted to the extent that
 the over-allotment&amp;#xA0;option is not exercised in full by the
 underwriters so that the Founder Shares will represent 20.0% of the
 Company&amp;#x2019;s issued and outstanding shares of common stock after
 the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The initial stockholders will agree, subject to limited exceptions,
 not to transfer, assign or sell any of the Founder Shares until the
 earlier to occur of: (A)&amp;#xA0;one year after the completion of the
 initial Business Combination or (B)&amp;#xA0;subsequent to the initial
 Business Combination, (x)&amp;#xA0;if the last reported sale price of
 the Class&amp;#xA0;A common stock equals or exceeds $12.00 per share
 (as adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 &lt;font style="WHITE-SPACE: nowrap"&gt;any&amp;#xA0;30-trading&amp;#xA0;day&lt;/font&gt; period
 commencing at least 150 days after the initial Business
 Combination, or (y)&amp;#xA0;the date on which the Company completes a
 liquidation, merger, capital stock exchange, reorganization or
 other similar transaction that results in all of the
 Company&amp;#x2019;s stockholders having the right to exchange their
 shares of common stock for cash, securities or other property.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Private Placement Warrants&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Sponsor will agree to purchase an aggregate of 5,975,000
 Private Placement Warrants (or 6,575,000 Private Placement Warrants
 if the underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised
 in full), at a price of $1.00 per Private Placement Warrant
 ($5,975,000 in the aggregate, or $6,575,000 if the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised in
 full) in a private placement that will occur simultaneously with
 the closing of the Proposed Public Offering. Each whole Private
 Placement Warrant is exercisable for one whole share of
 Class&amp;#xA0;A&amp;#xA0;common stock at a price of $11.50 per share,
 subject to adjustment. A portion of the proceeds from the sale of
 the Private Placement Warrants to the Sponsor will be added to the
 proceeds from the Proposed Public Offering to be held in the Trust
 Account. If the Company does not complete a Business Combination
 within the Combination Period, the Private Placement Warrants will
 expire worthless. The Private Placement Warrants will &lt;font style="WHITE-SPACE: nowrap"&gt;be&amp;#xA0;non-redeemable&amp;#xA0;for&amp;#xA0;cash&lt;/font&gt;
 (except as described below) and exercisable on a cashless basis so
 long as they are held by the Sponsor or its permitted
 transferees.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor will agree, subject to limited exceptions, not to
 transfer, assign or sell the Private Placement Warrants until 30
 days after the completion of the initial Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor agreed to loan the Company an
 aggregate of up to $300,000 to cover expenses related to the
 Proposed Public Offering pursuant to a promissory note (the
 &amp;#x201C;Note&amp;#x201D;). This loan &lt;font style="WHITE-SPACE: nowrap"&gt;is&amp;#xA0;non-interest&amp;#xA0;bearing&amp;#xA0;and&lt;/font&gt;
 payable on the earlier of October&amp;#xA0;31, 2020 and the completion
 of the Proposed Public Offering. As of May&amp;#xA0;5, 2020, the
 Company has borrowed $75,000 under the Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In addition, in order to fund working capital deficiencies or
 finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&amp;#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&amp;#x201C;Working Capital Loans&amp;#x201D;). If the Company completes a
 Business Combination, the Company may repay the Working Capital
 Loans out of the proceeds of the Trust Account released to the
 Company. Otherwise, the Working Capital Loans could be repaid only
 out of funds held outside the Trust Account. In the event that a
 Business Combination does not close, the Company may use a portion
 of proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans. The Working Capital Loans
 would either be repaid upon consummation of a Business Combination
 or, at the lender&amp;#x2019;s discretion, up to $1,500,000 of such
 Working Capital Loans may be convertible into warrants of the post
 Business Combination entity at a price of $1.00 per warrant. The
 warrants would be identical to the Private Placement Warrants.
 Except for the foregoing, the terms of such Working Capital Loans,
 if any, have not been determined and no written agreements exist
 with respect to such loans. To date, the Company had no borrowings
 under the Working Capital Loans.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Service and Administrative Fees&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company has agreed to pay service and administrative fees of
 $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the
 Company&amp;#x2019;s Chief Financial Officer, for up to 18 months
 commencing on the date of consummation of the Proposed Public
 Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor, executive officers and directors, or any of their
 respective affiliates, will be reimbursed for &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;any&amp;#xA0;out-of-pocket&amp;#xA0;expenses&amp;#xA0;incurred&lt;/font&gt;&lt;/font&gt;
 in connection with activities on the Company&amp;#x2019;s behalf such as
 identifying potential target businesses and performing due
 diligence on suitable Business Combinations. The Company&amp;#x2019;s
 audit committee will review on a quarterly basis all payments that
 were made by the Company to the Sponsor, officers, directors or
 their affiliates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 2&amp;#x2014;Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&amp;#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the balance sheet.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Deferred Offering Costs Associated with the Proposed Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&amp;#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&amp;#xA0;1, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&amp;#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&amp;#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 7&amp;#x2014;Subsequent Events&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Subsequent to May&amp;#xA0;1, 2020, the Company has borrowed $75,000
 under the Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company evaluated events that have occurred after the balance
 sheet date through May&amp;#xA0;8, 2020, which is the date on which
 these financial statements were issued. Based upon this review,
 except as below, the Company did not identify any other subsequent
 events that would have required adjustment or disclosure in the
 financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On June&amp;#xA0;25, 2020, the Company effected a stock dividend of
 718,750 shares, resulting in the Sponsor holding an aggregate of
 5,750,000 Founder Shares, of which an aggregate of up to 750,000
 shares are subject to forfeiture. All share and &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; amounts have been
 retroactively restated to reflect the stock dividend.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 As a result of the execution of the underwriting agreement on
 June&amp;#xA0;25, 2020, the financial statements have been modified to
 reflect the final terms of the agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&amp;#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">2500</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the balance sheet.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&amp;#xA0;1, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&amp;#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&amp;#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 6&amp;#x2014;Stockholder&amp;#x2019;s Equity&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;A Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 100,000,000&amp;#xA0;shares of
 Class&amp;#xA0;A common stock with a par value of $0.0001 per share. As
 of May&amp;#xA0;1, 2020, there were no shares of Class&amp;#xA0;A common
 stock issued or outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;B Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 10,000,000 shares of Class&amp;#xA0;B
 common stock with a par value of $0.0001 per share. On
 April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&amp;#xA0;shares of Class&amp;#xA0;B common stock, which was fully
 paid on May&amp;#xA0;1, 2020. On June&amp;#xA0;25, 2020, the Company
 effected a stock dividend with respect to the Class&amp;#xA0;B common
 stock, resulting in the Sponsor holding an aggregate of 5,750,000
 founder shares. All shares and associated amounts have been
 retroactively restated to reflect the share capitalization. Of
 these, an aggregate of up to 750,000 shares of Class&amp;#xA0;B common
 stock that are subject to forfeiture to the Company by the initial
 stockholders for no consideration to the extent that the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is not exercised in
 full or in part, so that the number of Founder Shares will equal
 20% of the Company&amp;#x2019;s issued and outstanding shares of common
 stock after the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 Stockholders of record are entitled to one vote for each share held
 on all matters to be voted on by stockholders; provided that, prior
 to the completion of the initial Business Combination, holders of
 the Class&amp;#xA0;B common stock will have the right to elect all of
 the Company&amp;#x2019;s directors and remove members of the
 Company&amp;#x2019;s board of directors for any reason. Prior to the
 completion of the initial Business Combination, only holders of the
 Class&amp;#xA0;B common stock will have the right to vote on the
 Company&amp;#x2019;s election of directors. Holders of the Public Shares
 will not be entitled to vote on the Company&amp;#x2019;s election of
 directors during such time. In addition, prior to the completion of
 the initial Business Combination, holders of a majority of the
 outstanding shares of the Class&amp;#xA0;B common stock may remove a
 member of the Company&amp;#x2019;s board of directors for any reason.
 These provisions of the Certificate of Incorporation may only be
 amended by a resolution passed by the holders of a majority of
 shares of the Class&amp;#xA0;B common stock. With respect to any other
 matter submitted to a vote of the Company&amp;#x2019;s stockholders,
 including any vote in connection with the initial Business
 Combination, holders of the Class&amp;#xA0;A common stock and holders
 of the Class&amp;#xA0;B common stock will vote together as a single
 class on all matters submitted to a vote of the Company&amp;#x2019;s
 stockholders, except as required by law.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Class&amp;#xA0;B common stock will automatically convert into
 Class&amp;#xA0;A common stock at the time of the initial Business
 Combination, or earlier at the option of the holders, on
 &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;one-for-one&amp;#xA0;basis,&amp;#xA0;subject&lt;/font&gt;&lt;/font&gt;
 to adjustment for stock splits, stock dividends, reorganizations,
 recapitalizations and the like, and subject to further adjustment
 as described herein. In the case that additional shares of
 Class&amp;#xA0;A common stock, or equity-linked securities, are issued
 or deemed issued in excess of the amounts issued in the Proposed
 Offering and related to the closing of the initial Business
 Combination, including pursuant to a specified future issuance, the
 ratio at which shares of Class&amp;#xA0;B common stock shall convert
 into shares of Class&amp;#xA0;A common stock will be adjusted (unless
 the holders of a majority of the then-outstanding shares of
 Class&amp;#xA0;B common stock agree to waive such adjustment with
 respect to any such issuance or deemed issuance, including a
 specified future issuance) so that the number of shares of
 Class&amp;#xA0;A common stock issuable upon conversion of all shares of
 Class&amp;#xA0;B common stock will equal, in the aggregate, on an
 &lt;font style="WHITE-SPACE: nowrap"&gt;as-converted&lt;/font&gt; basis, 20% of
 the sum of the total number of all shares of common stock
 outstanding upon the completion of the Proposed Public Offering
 plus all shares of Class&amp;#xA0;A common stock and equity-linked
 securities issued or deemed issued in connection with the initial
 Business Combination (excluding any shares or equity-linked
 securities issued or issuable to any seller in the initial Business
 Combination).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The Company is authorized to
 issue 1,000,000&amp;#xA0;shares of preferred stock, par value $0.0001
 per share, with such designations, voting and other rights and
 preferences as may be determined from time to time by the
 Company&amp;#x2019;s board of directors. As of May&amp;#xA0;1, 2020, there
 were no shares of preferred stock issued or outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&amp;#x2014;Public Warrants may only be exercised
 for a whole number of shares. No fractional Public Warrants will be
 issued upon separation of the Units and only whole Public Warrants
 will trade. The Public Warrants will become exercisable on the
 later of (a) 30 days after the completion of a Business Combination
 and (b) 12&amp;#xA0;months from the closing of the Proposed Public
 Offering; provided in each case that the Company has an effective
 registration statement under the Securities Act covering the
 issuance of the shares of Class&amp;#xA0;A common stock issuable upon
 exercise of the Public Warrants and a current prospectus relating
 to them is available and such shares are registered, qualified or
 exempt from registration under the securities, or blue sky, laws of
 the state of residence of the holder (or the Company permits
 holders to exercise their Public Warrants on a cashless basis under
 the circumstances specified in the warrant agreement). The Company
 has agreed that as soon as practicable, but in no event later than
 20 business days after the closing of the initial Business
 Combination, the Company will use its commercially reasonable
 efforts to file, and within 60 business days following the initial
 Business Combination to have declared effective, a registration
 statement covering the issuance of the shares of Class&amp;#xA0;A
 common stock issuable upon exercise of the warrants and to maintain
 a current prospectus relating to those shares of Class&amp;#xA0;A
 common stock until the warrants expire or are redeemed; provided,
 that if the Class&amp;#xA0;A common stock is at the time of any
 exercise of a warrant not listed on a national securities exchange
 such that it satisfies the definition of a &amp;#x201C;covered
 security&amp;#x201D; under Section&amp;#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their warrants to do so on a &amp;#x201C;cashless
 basis&amp;#x201D; in accordance with Section&amp;#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, it will not
 be required to file or maintain in effect a registration statement,
 but it will be required to use its best efforts to register or
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available. The Public Warrants will expire five
 years after the completion of a Business Combination or earlier
 upon redemption or liquidation.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The warrants will have an exercise price of $11.50 per share. If
 (x)&amp;#xA0;the Company issue additional shares or equity-linked
 securities for capital raising purposes in connection with the
 closing of the initial Business Combination at an issue price or
 effective issue price of less than $9.20 per share (as adjusted for
 stock splits, stock dividends, rights issuances, subdivisions,
 reorganizations, recapitalizations and the like) (with such issue
 price or effective issue price to be determined in good faith by
 the Company&amp;#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor, initial stockholders or their affiliates,
 without taking into account any Founder Shares held by them prior
 to such issuance) (the &amp;#x201C;Newly Issued Price&amp;#x201D;), (y) the
 aggregate gross proceeds from such issuances represent more than
 60% of the total equity proceeds, and interest thereon, available
 for the funding of the initial Business Combination on the date of
 the consummation of the Initial Business Combination (net of
 redemptions), and (z)&amp;#xA0;the volume weighted average trading
 price of the Company&amp;#x2019;s shares of Class&amp;#xA0;A common stock
 during the 20 trading day period starting on the trading day prior
 to the day on which the Company consummates the initial Business
 Combination (such price, the &amp;#x201C;Market Value&amp;#x201D;) is below
 $9.20 per share, the exercise price of each warrant will be
 adjusted (to the nearest cent) such that the effective exercise
 price per full share will be equal to 115% of the higher of
 (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued Price, and
 the $18.00 per share redemption trigger price described below will
 be adjusted (to the nearest cent) to be equal to 180% of the higher
 of (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued
 Price.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Private Placement Warrants will be identical to the Public
 Warrants, except that (1)&amp;#xA0;the Private Placement Warrants and
 the shares of Class&amp;#xA0;A common stock issuable upon exercise of
 the Private Placement Warrants will not be transferable, assignable
 or salable until 30 days after the completion of a Business
 Combination, subject to certain limited exceptions, (2)&amp;#xA0;the
 Private Placement Warrants will &lt;font style="WHITE-SPACE: nowrap"&gt;be&amp;#xA0;non-redeemable&lt;/font&gt; (except as
 described below) so&amp;#xA0;long as they are held by the Sponsor or
 its permitted transferees, (3)&amp;#xA0;the Private Placement Warrants
 may be exercised by the holders on a cashless basis and
 (4)&amp;#xA0;the holders of the Private Placement Warrants (including
 with respect to the shares of common stock issuable upon exercise
 of the Private Placement Warrants) are entitled to registration
 rights. If the Private Placement Warrants are held by someone other
 than the Sponsor or its permitted transferees, the Private
 Placement Warrants will be redeemable by the Company in all
 redemption scenarios and exercisable by such holders on the same
 basis as the Public Warrants.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company may call the Public Warrants for redemption:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at a price of $0.01 per warrant;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;upon a minimum of 30 days&amp;#x2019; prior written notice
 of redemption; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the last reported sale price of the
 Class&amp;#xA0;A common stock equals or exceeds $18.00 per share (as
 adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 &lt;font style="WHITE-SPACE: nowrap"&gt;the&amp;#xA0;30-trading&amp;#xA0;day&amp;#xA0;period&lt;/font&gt;
 ending on the third business day prior to the date on which the
 Company sends the notice of redemption to the warrant holders.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 If the Company calls the Public Warrants for redemption, management
 will have the option to require all holders that wish to exercise
 the Public Warrants to do so on a &amp;#x201C;cashless basis,&amp;#x201D; as
 described in the warrant agreement.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In addition, commencing ninety days after the warrants become
 exercisable, the Company may redeem the outstanding warrants:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at $0.10 per warrant upon a minimum of 30 days&amp;#x2019;
 prior written notice of redemption provided that holders will be
 able to exercise their warrants on a cashless basis prior to
 redemption and receive that number of shares of Class&amp;#xA0;A common
 stock to be determined by reference to a table in the warrant
 agreement;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the last reported sale price of the
 Company&amp;#x2019;s Class&amp;#xA0;A common stock equals or exceeds
 $10.00&amp;#xA0;per share (as adjusted for stock splits, stock
 dividends, reorganizations, recapitalizations and the like) on the
 trading day prior to the date on which the Company sends the notice
 of redemption to the warrant holders;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the Private Placement Warrants are
 also concurrently called for redemption at the same price (equal to
 a number of shares of Class&amp;#xA0;A common stock) as the outstanding
 Public Warrants, as described above; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, there is an effective registration
 statement covering the shares of Class&amp;#xA0;A common stock (or a
 security other than the Class&amp;#xA0;A common stock into which the
 Class&amp;#xA0;A common stock has been converted or exchanged for in
 the event the Company is not the surviving company in the initial
 Business Combination) issuable upon exercise of the warrants and a
 current prospectus relating thereto available throughout the
 &lt;font style="WHITE-SPACE: nowrap"&gt;30-day&lt;/font&gt; period after
 written notice of redemption is given.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In no event will the Company be required to net cash settle any
 warrant. If the Company is unable to complete a Business
 Combination within the Combination Period and the Company
 liquidates the funds held in the Trust Account, holders of warrants
 will not receive any of such funds with respect to their warrants,
 nor will they receive any distribution from the Company&amp;#x2019;s
 assets held outside of the Trust Account with the respect to such
 warrants. Accordingly, the warrants may expire worthless.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Note 1&amp;#x2014;Description of Organization, Business Operations
 and Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Kensington Capital Acquisition Corp. (the &amp;#x201C;Company&amp;#x201D;)
 was incorporated in Delaware on April&amp;#xA0;17, 2020. The Company
 was formed for the purpose of effecting a merger, capital stock
 exchange, asset acquisition, stock purchase, reorganization or
 similar business combination with one or more businesses
 (the&amp;#xA0;&amp;#x201C;Business Combination&amp;#x201D;). Although the Company
 is not limited to a particular industry or sector for purposes of
 consummating a Business Combination, the Company intends to focus
 its search for a target business in the automotive and
 automotive-related sector. The Company is an emerging growth
 company and, as such, the Company is subject to all of the risks
 associated with emerging growth companies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 As of May&amp;#xA0;1, 2020, the Company had not commenced any
 operations. All activity for the period from April&amp;#xA0;17, 2020
 (inception) through May&amp;#xA0;1, 2020 relates to the Company&amp;#x2019;s
 formation and the proposed initial public offering described below.
 The Company will not generate any operating revenues until after
 the completion of its initial Business Combination, at the
 earliest. The Company will &lt;font style="WHITE-SPACE: nowrap"&gt;generate&amp;#xA0;non-operating&amp;#xA0;income&amp;#xA0;in&lt;/font&gt;
 the form of interest income on cash and cash equivalents from the
 proceeds derived from the Proposed Public Offering (as&amp;#xA0;defined
 below). The Company has selected December&amp;#xA0;31 as its fiscal
 year end.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company&amp;#x2019;s sponsor is Kensington Capital Sponsor LLC, a
 Delaware limited liability company (the &amp;#x201C;Sponsor&amp;#x201D;). The
 Company&amp;#x2019;s ability to commence operations is contingent upon
 obtaining adequate financial resources through a proposed public
 offering (the &amp;#x201C;Proposed Public Offering&amp;#x201D;) of 20,000,000
 units (each, a &amp;#x201C;Unit&amp;#x201D; and collectively, the
 &amp;#x201C;Units&amp;#x201D;) at $10.00 per Unit (or 23,000,000 units if the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised in
 full), which is discussed in Note&amp;#xA0;3, and the sale of 5,975,000
 warrants (or 6,575,000 warrants if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full) (each, a
 &amp;#x201C;Private Placement Warrant&amp;#x201D; and collectively, the
 &amp;#x201C;Private Placement Warrants&amp;#x201D;), at a price of $1.00 per
 Private Placement Warrant in a private placement to the Sponsor
 that will close simultaneously with the Proposed Public
 Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company&amp;#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Proposed Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. There is no
 assurance that the Company will be able to complete a Business
 Combination successfully. The Company must complete an initial
 Business Combination with one or more operating businesses or
 assets with a fair market value equal to at least 80% of the net
 assets held in the Trust Account (as defined below) (net of amounts
 disbursed to management for working capital purposes, if permitted,
 and excluding the amount of any deferred underwriting discount).
 However, the Company will only complete a Business Combination if
 the post-transaction&amp;#xA0;company owns or acquires 50% or more of
 the outstanding voting securities of the target or otherwise
 acquires a controlling interest in the target business sufficient
 for it not to be required to register as an investment company
 under the Investment Company Act 1940, as amended (the
 &amp;#x201C;Investment Company Act&amp;#x201D;). Upon the closing of the
 Proposed Public Offering, management has agreed that an amount
 equal to at least $10.00 per Unit sold in the Proposed Public
 Offering, including proceeds from the sale of the Private Placement
 Warrants to the Sponsor, will be held in a trust account
 (&amp;#x201C;Trust Account&amp;#x201D;) located in the United States with
 Continental Stock Transfer&amp;#xA0;&amp;amp; Trust Company acting as
 trustee, and invested only in U.S. &amp;#x201C;government
 securities,&amp;#x201D; within the meaning set forth in
 Section&amp;#xA0;2(a)(16)&amp;#xA0;of the Investment Company Act, with a
 maturity of 185 days or less, or in money market funds meeting
 certain conditions under &lt;font style="WHITE-SPACE: nowrap"&gt;Rule&amp;#xA0;2a-7&amp;#xA0;under&amp;#xA0;the&lt;/font&gt;
 Investment Company Act, which invest only in direct U.S. government
 treasury obligations, as determined by the Company, until the
 earlier of: (i)&amp;#xA0;the completion of a Business Combination and
 (ii)&amp;#xA0;the distribution of the Trust Account as described
 below.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company will provide holders of the Company&amp;#x2019;s outstanding
 shares of Class&amp;#xA0;A common stock, par value $0.0001 per share,
 sold in the Proposed Public Offering (the &amp;#x201C;Public
 Stockholders&amp;#x201D;) with the opportunity to redeem all or a
 portion of their Public Shares (as defined below) upon the
 completion of a Business Combination either
 (i)&amp;#xA0;in&amp;#xA0;connection with a stockholder meeting called to
 approve the Business Combination or (ii)&amp;#xA0;by means of a tender
 offer. The decision as to whether the Company will seek stockholder
 approval of a Business Combination or conduct a tender offer will
 be made by the Company, solely in its discretion. The Public
 Stockholders will be entitled to redeem their Public Shares for a
 pro rata portion of the amount then held in the Trust Account
 (initially anticipated to be $10.00 per Public Share), calculated
 as of two business days prior to the initial Business Combination,
 including interest earned on the funds held in the trust account
 and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable. &lt;font style="WHITE-SPACE: nowrap"&gt;The&amp;#xA0;per-share&amp;#xA0;amount&amp;#xA0;to&lt;/font&gt;
 be distributed to Public Stockholders who redeem their Public
 Shares will not be reduced by the deferred underwriting commissions
 the Company will pay to the underwriters (as discussed in Note 5).
 These Public Shares will be recorded at a redemption value and
 classified as temporary equity upon the completion of the Proposed
 Public Offering in accordance with the Financial Accounting
 Standards Board&amp;#x2019;s (&amp;#x201C;FASB&amp;#x201D;) Accounting Standards
 Codification (&amp;#x201C;ASC&amp;#x201D;) Topic 480 &amp;#x201C;Distinguishing
 Liabilities from Equity.&amp;#x201D; The Company will proceed with a
 Business Combination if a majority of the shares voted are voted in
 favor of the Business Combination. The Company will not redeem the
 Public Shares in an amount that would cause its net tangible assets
 to be less than $5,000,001. If a stockholder vote is not required
 by applicable law or stock exchange rule and the Company does not
 decide to hold a stockholder vote for business or other reasons,
 the Company will, pursuant to its amended and restated certificate
 of incorporation (the &amp;#x201C;Certificate of Incorporation&amp;#x201D;),
 conduct the redemptions pursuant to the tender offer rules of the
 U.S. Securities and Exchange Commission (&amp;#x201C;SEC&amp;#x201D;) and
 file tender offer documents with the SEC prior to completing a
 Business Combination. If, however, stockholder approval of the
 transaction is required by applicable law or stock exchange rule,
 or the Company decides to obtain stockholder approval for business
 or reasons, the Company will offer to redeem shares in conjunction
 with a proxy solicitation pursuant to the proxy rules and not
 pursuant to the tender offer rules. Additionally, each Public
 Stockholder may elect to redeem their Public Shares without voting,
 and if they do vote, irrespective of whether they vote for or
 against the proposed transaction. If the Company seeks stockholder
 approval in connection with a Business Combination, the initial
 stockholders (as defined below) have agreed to vote any Founder
 Shares (as defined below in Note 4) and any Public Shares held by
 them in favor of a Business Combination. In addition, the initial
 stockholders have agreed to waive their redemption rights with
 respect to any Founder Shares and any Public Shares held by them in
 connection with the completion of a Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Certificate of Incorporation will provide that a Public
 Stockholder, together with any affiliate of such stockholder or any
 other person with whom such stockholder is acting in concert or as
 a &amp;#x201C;group&amp;#x201D; (as defined under Section&amp;#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &amp;#x201C;Exchange
 Act&amp;#x201D;)), will be restricted from redeeming its shares with
 respect to more than an aggregate of 15% or more of the Public
 Shares, without the prior consent of the Company.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor and the Company&amp;#x2019;s officers and directors (the
 &amp;#x201C;initial stockholders&amp;#x201D;) have agreed, pursuant to a
 letter agreement with the Company, that they will not propose any
 amendment to the Certificate of Incorporation (A)&amp;#xA0;to modify
 the substance or timing of the Company&amp;#x2019;s obligation to allow
 redemption in connection with the initial Business Combination or
 to redeem 100% of the Public Shares if the Company does not
 complete a Business Combination within the Combination Period (as
 defined below) or (B)&amp;#xA0;with respect to any other provision
 relating to stockholders&amp;#x2019; rights &lt;font style="WHITE-SPACE: nowrap"&gt;or&amp;#xA0;pre-initial&amp;#xA0;Business&lt;/font&gt;
 Combination activity, unless the Company provides the Public
 Stockholders with the opportunity to redeem their Public Shares
 upon approval of any such amendment at a &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; price, payable in cash,
 equal to the aggregate amount then on deposit in the Trust Account,
 including interest (which interest shall be net of taxes payable)
 divided by the number of then outstanding Public Shares.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 If the Company is unable to complete a Business Combination within
 24&amp;#xA0;months from the closing of the Proposed Public Offering (as
 such period may be extended pursuant to the Certificate of
 Incorporation, the &amp;#x201C;Combination Period&amp;#x201D;), the Company
 will (i)&amp;#xA0;cease all operations except for the purpose of
 winding up, (ii)&amp;#xA0;as promptly as reasonably possible but not
 more than ten business days thereafter, redeem the Public Shares,
 at &lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;per-share&amp;#xA0;price,&lt;/font&gt; payable
 in cash, equal to the aggregate amount then on deposit in the Trust
 Account including interest earned on the funds held in the Trust
 Account and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable (less up to $100,000 of
 interest to pay dissolution expenses), divided by the number of
 then outstanding Public Shares, which redemption will completely
 extinguish Public Stockholders&amp;#x2019; rights as stockholders
 (including the right to receive further liquidating distributions,
 if any), and (iii)&amp;#xA0;as promptly as reasonably possible
 following such redemption, subject to the approval of the
 Company&amp;#x2019;s remaining stockholders and the Company&amp;#x2019;s
 board of directors, dissolve and liquidate, subject in each case to
 the Company&amp;#x2019;s obligations under Delaware law to provide for
 claims of creditors and the requirements of other applicable law.
 There will be no redemption rights or liquidating distributions
 with respect to the Company&amp;#x2019;s warrants, which will expire
 worthless if the Company fails to complete its initial Business
 Combination within the Combination Period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The initial stockholders have agreed to waive their rights to
 liquidating distributions from the Trust Account with respect to
 any Founder Shares held by them if the Company fails to complete a
 Business Combination within the Combination Period. However, if the
 initial stockholders acquire Public Shares in or after the Proposed
 Public Offering, they will be entitled to liquidating distributions
 from the Trust Account with respect to such Public Shares if the
 Company fails to complete a Business Combination within the
 Combination Period. The underwriters have agreed to waive their
 rights to the deferred underwriting commission (see Note 5) held in
 the Trust Account in the event the Company does not complete a
 Business Combination within in the Combination Period and, in such
 event, such amounts will be included with the other funds held in
 the Trust Account that will be available to fund the redemption of
 the Public Shares. In the event of such distribution, it is
 possible that the per share value of the residual assets remaining
 available for distribution (including Trust Account assets) will be
 only, or less than, $10.00. In order to protect the amounts held in
 the Trust Account, the Sponsor has agreed to be liable to the
 Company if and to the extent any claims by a third party (except
 for the Company&amp;#x2019;s independent registered public accounting
 firm) for services rendered or products sold to the Company, or a
 prospective target business with which the Company has discussed
 entering into a transaction agreement (a &amp;#x201C;Target&amp;#x201D;),
 reduce the amount of funds in the Trust Account to below the lesser
 of (i) $10.00 per Public Share and (ii)&amp;#xA0;the actual amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account, if less than $10.00 per Public
 Share due to reductions in the value of the trust assets, less
 taxes payable, provided that such liability will not apply to any
 claims by a third party or Target that executed a waiver of any and
 all rights to the monies held in the Trust Account nor will it
 apply to any claims under the Company&amp;#x2019;s indemnity of the
 underwriters of the Proposed Public Offering against certain
 liabilities, including liabilities under the Securities Act of
 1933, as amended (the &amp;#x201C;Securities Act&amp;#x201D;). Moreover, in
 the event that an executed waiver is deemed to be unenforceable
 against a third party, then the Sponsor will not be responsible to
 the extent of any liability for such third-party claims. The
 Company will seek to reduce the possibility that the Sponsor will
 have to indemnify the Trust Account due to claims of creditors by
 endeavoring to have all vendors, service providers, prospective
 target businesses and other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 As of May&amp;#xA0;1, 2020, the Company had $25,000 in cash and a
 working capital deficiency of $39,000. Further, the Company has
 incurred and expect to continue to incur significant costs in
 pursuit of its financing and acquisition plans. Management&amp;#x2019;s
 plans to address this need for capital through the Proposed Public
 Offering. The Company cannot assure that its plans to raise capital
 or to consummate an initial Business Combination will be
 successful. These factors, among others, raise substantial doubt
 about the Company&amp;#x2019;s ability to continue as a going concern.
 The financial statements do not include any adjustments that might
 result from its inability to consummate the Proposed Public
 Offering or its inability to continue as a going concern.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The accompanying financial statements are presented in U.S. dollars
 in conformity with accounting principles generally accepted in the
 United States of America (&amp;#x201C;U.S. GAAP&amp;#x201D;) and pursuant to
 the rules and regulations of the SEC.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 5&amp;#x2014;Commitments&amp;#xA0;&amp;amp; Contingencies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The holders of Founder Shares, Private Placement Warrants and
 warrants that may be issued upon conversion of Working Capital
 Loans, if any, and any shares of Class&amp;#xA0;A common stock issuable
 upon the exercise of the Private Placement Warrants and warrants
 that may be issued upon conversion of Working Capital Loans and
 upon conversion of the Founder Shares will be entitled to
 registration rights pursuant to a registration rights agreement to
 be signed prior to the consummation of the Proposed Public
 Offering. These holders will be entitled to certain demand and
 &amp;#x201C;piggyback&amp;#x201D; registration rights. The Company will bear
 the expenses incurred in connection with the filing of any such
 registration statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The underwriters will be entitled to an underwriting discount of
 $0.20 per unit, or $4,000,000 in the aggregate (or approximately
 $4,600,000 in the aggregate if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full), payable upon the
 closing of the Proposed Public Offering. $0.35 per unit, or
 approximately $7,000,000 in the aggregate (or approximately
 $8,050,000 in the aggregate if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full) will be payable to
 the underwriters for deferred underwriting commissions. The
 deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">-2500</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="2">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
  <kcac:InitialPublicOfferingDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 3&amp;#x2014;Proposed Public Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Pursuant to the Proposed Public Offering, the Company intends to
 offer for sale 20,000,000 units at a price of $10.00 per Unit. Each
 Unit consists of one share of Class&amp;#xA0;A common stock (such
 shares of common stock included in the Units being offered, the
 &amp;#x201C;Public Shares&amp;#x201D;), &lt;font style="WHITE-SPACE: nowrap"&gt;and&amp;#xA0;one-half&amp;#xA0;of&amp;#xA0;one&lt;/font&gt;
 redeemable warrant (each, a &amp;#x201C;Public Warrant&amp;#x201D;). Each
 whole Public Warrant entitles the holder to purchase one share of
 Class&amp;#xA0;A common stock at a price of $11.50 per share, subject
 to adjustment (see Note 6).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company will grant the underwriters &lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;45-day&amp;#xA0;option&amp;#xA0;from&lt;/font&gt;
 the date of the final prospectus relating to the Proposed Public
 Offering to purchase up to 3,000,000 additional Units to cover
 over-allotments, if any, at the Proposed Public Offering price,
 less underwriting discounts and commissions.&lt;/p&gt;
 &lt;/div&gt;</kcac:InitialPublicOfferingDisclosureTextBlock>
  <kcac:OfferingCostsPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Deferred Offering Costs Associated with the Proposed Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.&lt;/p&gt;
 &lt;/div&gt;</kcac:OfferingCostsPolicyTextBlock>
  <kcac:NonCashOfferingCostsIncludedInAccruedExpenses contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0">61500</kcac:NonCashOfferingCostsIncludedInAccruedExpenses>
  <kcac:DescriptionOfPublicWarrant contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">Each Unit consists of one share  of Class A common stock (such shares of common stock included in the Units being  offered, the "Public Shares"), and one-half of one redeemable warrant (each, a  "Public Warrant").</kcac:DescriptionOfPublicWarrant>
  <kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">P30D</kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="INF">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:PercentageOfPublicSharesToBeRedeemed contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_pure" decimals="INF">1.00</kcac:PercentageOfPublicSharesToBeRedeemed>
  <kcac:PublicWarrantsExpirationTerm contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0">P5Y</kcac:PublicWarrantsExpirationTerm>
  <kcac:PercentageOfProceedsFromShareIssuances contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_pure" decimals="2">0.60</kcac:PercentageOfProceedsFromShareIssuances>
  <kcac:ExercisePriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_pure" decimals="2">1.15</kcac:ExercisePriceAdjustmentPercentage>
  <kcac:RedemptionTriggerPriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_pure" decimals="2">1.80</kcac:RedemptionTriggerPriceAdjustmentPercentage>
  <kcac:PercentageOfSharesToBeRedeemedWithoutConsent contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_pure" decimals="2">0.15</kcac:PercentageOfSharesToBeRedeemedWithoutConsent>
  <kcac:ProposedPublicOfferingSharePrice contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_xbrli_shares" decimals="INF">10.00</kcac:ProposedPublicOfferingSharePrice>
  <kcac:NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="INF">20000000</kcac:NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation>
  <kcac:NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="INF">23000000</kcac:NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull>
  <kcac:NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="INF">5975000</kcac:NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation>
  <kcac:NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="xbrli_shares" decimals="INF">6575000</kcac:NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629" unitRef="iso4217_USD" decimals="0">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <kcac:PeriodOfService contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629_4078739x4078757">P18M</kcac:PeriodOfService>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003_S-4_A">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003_S-4_A">24425</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4072861">P30D</kcac:NumberOfTradingDays>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4078721" unitRef="xbrli_shares" decimals="0">6575000</kcac:ClassOfWarrantsOrRightsIssued>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4268695" unitRef="xbrli_shares" decimals="INF">5975000</kcac:ClassOfWarrantsOrRightsIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003_S-4_A">575</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="xbrli_shares" decimals="INF" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004_S-4_A">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="xbrli_pure" decimals="2">0.20</kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4076805" unitRef="iso4217_USD" decimals="0">-2500</us-gaap:NetIncomeLoss>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4086031_4071742x4300621" unitRef="iso4217_USD" decimals="0">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4070963x4072861_4078716x4078721_4082399x4078609" unitRef="xbrli_shares" decimals="0">750000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4078721" unitRef="xbrli_shares" decimals="INF">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4260553" unitRef="iso4217_USD" decimals="0">4600000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4412415" unitRef="xbrli_shares" decimals="INF">20000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfTradingDaysEndingOnThirdBusinessDay contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695">P30D</kcac:NumberOfTradingDaysEndingOnThirdBusinessDay>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_xbrli_shares" decimals="INF">10.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4319093_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4412415">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:IpoExcludingOverAllotmentMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4260553">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:UnderwritersExerciseOfOverallotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4078721">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4070963x4072861_4078716x4078721_4082399x4078609">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4086031_4071742x4300621">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4076805">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4268695">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4078721">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4072861">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4069234x4082574">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629_4078739x4078757">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-17</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4070963x4072861_4078716x4078721_4078739x4405944_4085460x4085461">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-06-25</xbrli:startDate>
      <xbrli:endDate>2020-06-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-06-25</xbrli:startDate>
      <xbrli:endDate>2020-06-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_1_20200501_0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-05-01</xbrli:startDate>
      <xbrli:endDate>2020-05-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4085460x4085461">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4319093_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4268695">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4260553">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:UnderwritersExerciseOfOverallotmentOptionMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4070963x4072861">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4082574">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4076805">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4082399x4078608">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4071742x4263611_4078716x4078717">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
      <xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
<xbrli:context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001811414</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-05-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
</xbrli:xbrl>










